Aerosolised formulations from non-combustible substance delivery

An aerosolised formulation with identified chemical markers replicates the flavor and irritation of traditional cigarettes, improving the user experience in non-combustible smoking devices.

WO2026234398A1PCT designated stage Publication Date: 2026-11-12NICOVENTURES TRADING LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/GB2026/050801
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-09
Filing Date
2026-05-11
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Existing non-combustible smoking devices fail to fully replicate the flavor and irritation sensations of traditional cigarette smoking, limiting consumer acceptance.

Method used

An aerosolised formulation comprising specific compounds, including irritation and flavor markers, is developed to replicate the 'FMC-like' experience by aerosolising a composition in a non-combustible substance delivery system, such as heat-not-burn or vaping devices.

Benefits of technology

The formulation provides a more authentic cigarette-like experience by delivering tobacco aroma and irritation, enhancing user satisfaction and acceptance of non-combustible devices.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IMGF000025_0001
    Figure IMGF000025_0001
  • Figure IMGF000076_0001
    Figure IMGF000076_0001
  • Figure IMGF000077_0001
    Figure IMGF000077_0001
Patent Text Reader

Abstract

The present disclosure relates to an aerosolised formulation obtained by aerosolising a composition in a non-combustible substance delivery system. The aerosolised formulation is advantageous in contributing to a factory-made cigarette (FMC)-like experience. Also provided is the composition for use in a non-combustible substance delivery system.
Need to check novelty before this filing date? Find Prior Art

Description

AEROSOLISED FORMULATIONS FROM NON-COMBUSTIBLE SUBSTANCE DELIVERY SYSTEMSTechnical Field

[0001] The present disclosure relates to an aerosolised formulation obtained by aerosolising a composition in a non-combustible substance delivery system. The aerosolised formulation is advantageous in contributing to a factory-made cigarette (FMC)-like experience. Also provided is the composition for use in a non-combustible substance delivery system.Background

[0002] Smoking articles such as cigarettes, cigars, and the like, burn tobacco during use to create tobacco smoke. Alternatives to these types of articles release an inhalable aerosol or vapour by releasing compounds from a substrate material by heating without burning. These may be referred to as non-combustible smoking articles, aerosol-generating assemblies, or non-combustible aerosol provision systems. One example of such a product is a heating device which releases compounds by heating, but not burning, a solid aerosolisable material. This solid aerosolisable material may, in some cases, contain a tobacco material. The heating volatilises at least one component of the material, typically forming an inhalable aerosol. These products may be referred to as heat-not-burn devices, tobacco heating devices or tobacco heating products. Various different arrangements for volatilising at least one component of the solid aerosolisable material are known.

[0003] As another example, there are e-cigarette / tobacco heating product hybrid devices, also known as electronic tobacco hybrid devices. These hybrid devices contain a liquid source, which may or may not contain nicotine, which is vaporised by heating to produce an inhalable vapour or aerosol. The device additionally contains a solid aerosolisable material, which may or may not contain a tobacco material, and components of this material are entrained in the inhalable vapour or aerosol to produce the inhaled medium. A further alternative is vapour products which are handheld, battery-powered devices that heat a liquid to produce an inhalable aerosol, commonly known as vapour.

[0004] The consumables used in heated products and vaping platforms, can also be used in oral products which are consumed by the user.Summary

[0005] In accordance with some aspects of the invention described herein, there is provided an aerosolised formulation obtained by aerosolising a composition in a non-combustible substancedelivery system. The aerosolised formulation comprises at least one compound from group (a) and at least two compounds from group (b). Group (a) may be referred to herein as the “key irritation markers list”. Group (b) may be referred to herein as the “key tobacco flavour markers list”. Group (a) is 1,6,10,14-hexadecatetraene-3-ol,3,7,11,15-tetramethyl-, (e.g. 1,6,10,14-hexadecatetraene-3-ol,3,7,11,15-tetramethyl-,(E,E)), and 3-methyl-1H-pyrazole-4-carbaldehyde. Group (b) is phenylacetaldehyde, Nonanal, toluene, ethylbenzene, dodecane, 2,3’-dipyridyl, butanal, 3-methyl-, 1,2-propanediol, 1-acetate, tetradecane, pentanal, 2,3-pentanedione, 6,8-nonadiene-2-one, 8-methyl-5-(1 -methylethyl)-, and guaiacol.

[0006] In some examples, the at least two compounds from group (b) include butanal, 3-methyl. In some examples, the at least two compounds from group (b) are selected from Phenylacetaldehyde, Nonanal, Toluene, Ethylbenzene, Dodecane, 2,3’-dipyridyl, 1,2-propanediol, 1-acetate, Tetradecane, Pentanal, 2,3-pentanedione, and 6,8-nonadiene-2-one, 8-methyl-5-(1 -methylethyl)-.

[0007] In some examples, the aerosolised formulation comprises at least three compounds from group (b). In some examples, the aerosolised formulation comprises at least four compounds from group (b). In some examples, the aerosolised formulation comprises at least five compounds from group (b). In some examples, the aerosolised formulation comprises at least six compounds from group (b). In some examples, the aerosolised formulation includes all of the compounds from group (b).

[0008] In some examples, the at least one compound from group (a) is 1,6,10,14-hexadecatetraen-3-ol,3,7,11,15-tetramethyl-. In such examples, this compound may be present in an amount of at least about 60 ng / puff.

[0009] In some examples, the at least two compounds from group (b) are selected from: Phenylacetaldehyde, Nonanal, Toluene, Ethylbenzene, Dodecane, 2,3’-dipyridyl, 1,2-propanediol, 1-acetate, Tetradecane, Pentanal, and Guaiacol. In some examples, the formulation comprises at least three compounds from this group (b) list. In some examples, the formulation comprises at least four compounds from this group (b) list. In some examples, the formulation comprises at least five compounds from this group (b) list. In some examples, the formulation comprises at least six compounds from this group (b) list. In some examples, the formulation comprises all of the compounds from this group (b) list.

[0010] In some examples, the at least one compound from group (a) is 3-methyl-1 H-pyrazole-4-carboxyaldehyde. In such examples, this compound may be present in an amount of at least about 1 ng / puff.

[0011] In some examples, the concentration of the compounds from group (a) and group (b) in the formulation (i.e. the total concentration of compounds from both groups) is at least about 500 ng / puff. In some examples, the concentration of the compounds from groups (a) and (b) in the formulation is at least about 1000 ng / puff.

[0012] In some examples, the formulation further comprises phenylethylalcohol and / or ethanone, 1-(1 H-pyrrol-2-yl)-. In some examples, the total amount of phenylethylalcohol and ethanone, 1-(1 H-pyrrol-2-yl)- is at least abo / ut 10 ng / puff. In some examples, the formulation further comprises myosmine and cotinine. Myosmine and cotinine may be present in an amount of at least about 75 ng / puff.

[0013] In some examples, the composition aerosolised in the non-combustible substance delivery system comprises at least one compound obtained by extraction from a plant material, e.g. a tobacco material. In some examples, the composition comprises at least one compound from group (a) and at least two compounds from group (b).

[0014] In some examples, the composition further comprises one or more compounds selected from: cotinine, myosmine, D-limonene, 3-methyl pentanoic acid, phenol, 6-ethyl-5,6-dihydro-2H-pyran-2-one, nicotyrine, and 2,3-dihydro-benzofuran.

[0015] In some examples, the composition further comprises one or more compounds selected from: acetic acid, 2-furanmethanol, 2-Furancarboxaldehyde, 5-methyl-, Benzyl alcohol, Menthol, Indole, 2-Methoxy-4-vinylphenol, 6,8-Nonadien-2-one, 8-methyl-5-(1-methylethyl)-(e.g. 8-methyl-5-(1 -methylethyl)-, (E)-), Nicotyrine, 2(4H)-Benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl- (e.g. 5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, (R)-), 2-Cyclohexen-1-one, 4-(3-hydroxybutyl)-3,5,5-trimethyl-, Cembrene, n-Hexadecanoic acid, Scopoletin, Octadecanoic acid, and 9,12,15-Octadecatrienoic acid (e.g. 9,12,15-octadecatrienoic acid, (Z,Z,Z)-).

[0016] In some examples, the composition further comprises cotinine, myosmine, D-limonene, and nicotyrine, and optionally one or more compounds selected from: 3-methyl Pentanoic acid, phenol, 2-pyrrolidinone, 6-ethyl-5,6-dihydro-2H-pyran-2-one, and 2,3-dihydro-benzofuran. In some examples, the composition further comprises cotinine, myosmine, D-limonene, nicotyrine, acetic acid, 2-furanmethanol, 2-furancarboxaldehyde, 5-methyl-, menthol, 6,8-Nonadien-2-one, 8-methyl-5-(1 -methylethyl)-, 2-Cyclohexen-1-one, 4-(3-hydroxybutyl)-3,5,5-trimethyl-, Cembrene, n-Hexadecanoic acid, Octadecanoic acid, 9,12,15-Octadecatrienoic acid, and optionally one or more compounds selected from 3-methyl Pentanoic acid, phenol, 2-pyrrolidinone, 6-ethyl-5,6-dihydro-2H-pyran-2-one, 2,3-dihydro-benzofuran, Benzyl alcohol,Indole, 2-Methoxy-4-vinylphenol (e.g. 2-methoxy-4-vinylphenol, (E)-), Nicotyrine, 2(4H)-Benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, and Scopoletin.

[0017] In some examples, the composition further comprises nicotine.

[0018] In some examples, the aerosolised formulation comprises at least one organic acid selected from: isovaleric acid, 3-methylpentanoic acid, phenylacetic acid, valeric acid, levulinic acid, 2-methylvaleric acid, 2-methylbutyric acid, heptanoic acid, isobutyric acid, acetic acid, butryric acid, and combinations thereof. In some examples, the at least one organic acid is selected from: phenylacetic acid, isovaleric acid, heptanoic acid, and combinations thereof. In other examples, the at least one organic acid is selected from: isovaleric acid, 3-methylpentanoic acid, phenylacetic acid, valeric acid, levulinic acid, 2-methylbutyric acid, isobutyric acid, acetic acid, and combinations thereof. In some examples, the at least one organic acid is selected from: isovaleric acid, 3-methylpentanoic acid, valeric acid, levulinic acid, 2-methylbutyric acid, isobutyric acid, acetic acid, and combinations thereof.

[0019] These and other features, aspects and advantages of the disclosure will be apparent from the following detailed description and drawings. The invention includes any combination of two, three, four, or more of the above-noted examples as well as combinations of any two, three, four, or more features or elements set forth in this disclosure, regardless of whether such features or elements are expressly combined in a specific example description herein. This disclosure is intended to be read holistically such that any separable features or elements of the disclosed invention, in any of its various aspects and examples, should be viewed as intended to be combinable unless the context clearly dictates otherwise.Brief Description of the FiguresFigure 1 demonstrates location of irritation across samples 1-3 tested in Example 6.Figure 2 demonstrates location of irritation across samples 4-6 tested in Example 6.Detailed Description

[0020] It is to be understood that this disclosure is not limited to the particular configurations, process steps, and materials disclosed herein as such configurations, process steps, and materials may vary somewhat. It is also to be understood that the terminology employed herein is used for the purpose of describing particular embodiments only and is not intended to be limiting since the scope will be limited only by the appended claims and equivalents thereof.

[0021] As used in this specification and the claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. Reference to "dry % byweight" or "dry weight basis" refers to weight on the basis of dry ingredients (i.e., all ingredients except water or carrier). Reference to "wet weight" refers to the weight of the formulation or consumable including water or carrier. Unless otherwise indicated, reference to "% by weight" (or “% by weight”) of formulation or consumable reflects the total wet weight of the formulation or consumable (i.e., including water / carrier).

[0022] In this specification, unless otherwise stated, the term "about" modifying the quantity of an ingredient in the formulation or employed in the methods refers to variation in the numerical quantity that can occur, for example, through typical measuring and liquid handling procedures used for making concentrates or use solutions in the real world; through inadvertent error in these procedures; through differences in the manufacture, source, or purity of the ingredients employed to make the formulation, or to carry out the methods; and the like. The term “about” also encompasses amounts that differ due to different equilibrium conditions for a formulation or consumable resulting from a particular initial mixture. Whether or not modified by the term "about", the claims include equivalents to the quantities.

[0023] The ranges provided herein relate to preferred amounts of each of the compound groups. Each of these ranges may be taken alone or combined with one or more other compound group range(s) to provide a preferred example of the invention.

[0024] As used herein, “substantially free” means no more than trace amounts, i.e. the amount of the substance(s) concerned is negligible. In various examples, “substantially free” means no more than 1000 ppm, preferably no more than 100 ppm, more preferably no more than 10 ppm, even more preferably no more than 1 ppm of the substance(s) concerned.

[0025] In all aspects of the present disclosure, the disclosure includes, where appropriate, all enantiomers and tautomers of the compounds disclosed herein. A person skilled in the art will recognise compounds that possess optical properties (one or more chiral carbon atoms) or tautomeric characteristics. The corresponding enantiomers and / or tautomers may be isolated / prepared by methods known in the art. Some of the compounds disclosed herein may exist as stereoisomers and / or geometric isomers - e.g. they may possess one or more asymmetric and / or geometric centres and so may exist in two or more stereoisomeric and / or geometric forms. The present disclosure contemplates the use of all the individual stereoisomers and geometric isomers of those compounds, and mixtures thereof. The terms used in the claims encompass these forms.

[0026] As used herein, an alkyl group can be a substituted or unsubstituted, linear or branched chain saturated radical. Examples of alkyl groups include methyl, ethyl, propyl, butyl, pentyl,hexyl, heptyl, octyl, nonyl, decyl, dodecyl, hexadecyl, heptadecyl, octadecyl, nondecyl, eicosyl, and isomeric forms thereof. Cycloalkyl groups are derived from cycloalkanes by removal of a hydrogen atom from a ring carbon atom; they include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 2-methylcyclopentyl, 2,3-dimethyl-cyclobutyl, 4-methylcyclobutyl, 3-cyclopentylpropyl, and the like.

[0027] As used herein, an alkenyl group can be a substituted or unsubstituted, linear, branched or cyclic unsaturated radical. An alkenyl group thus contains one or more carboncarbon double bonds. Examples of alkenyl groups include ethenyl, propenyl, butenyl, pentenyl, hexenyl, heptenyl, octenyl, nonenyl, decenyl, dodecenyl, hexadecenyl, heptadecenyl, octadecenyl, nondecenyl, eicosenyl, and isomeric forms thereof. Cycloalkenyl groups include cyclobutenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, cyclooctenyl, and the like, and isomeric forms thereof.

[0028] As used herein, an aromatic group is a substituted or unsubstituted group derived from arenes by removal of a hydrogen atom from a ring carbon atom. Aryl groups include phenyl, tolyl, xylyl, naphthyl, biphenylyl, and the like.

[0029] A cigarette, also known as a factory-made cigarette or ‘FMC’, gives rise to a cigarettelike or FMC-like experience when smoked by a consumer. Such an experience can have various dimensions, including sense, taste and flavour dimensions. By the ‘sense’ of a cigarette, is meant the overall feel of smoking a cigarette which includes attributes such as impact, irritation, harshness, mouth drying, and mouth coating or mouthfeel. By the “taste” of a cigarette is meant the overall taste of smoking a cigarette including hay-like, bread-like, smoky, tannin, resinous, musk, etc., and by the “flavour” of a cigarette is meant the overall flavour of smoking cigarette such as creamy, fruity, floral, green, spicy, savoury, roasted, woody, etc.

[0030] As noted above, there are several alternative means by which a consumer can replicate the smoking experience. These include e-cigarettes and tobacco heating devices which provide the consumer with an inhalable aerosol. One potential drawback with such devices is, however, that they may fail to completely replicate one or more of the dimensions associated with the FMC-like experience. Dimensions that are particularly critical for consumers are “flavour” and “sense”. With an inhalable aerosol, flavour is delivered primarily via aroma. Hence, when a consumer is seeking an “FMC-like experience” with a heating device (whether with a solid, liquid, gel or hybrid aerosolisable formulation(s)), it is desirable for the aroma to replicate that of smoking a cigarette, i.e. for the aroma to be tobacco-like and deliver a richness and complexity comparable to smoking a cigarette. It is also desirable for the “sensation” to be comparable tosmoking a cigarette; in particular, for the inhaled aerosol to deliver irritation to the mouth, nose and / or throat of the consumer.

[0031] The present disclosure relates to a combination of ingredients which are present in an aerosolised formulation obtained by aerosolising a composition in a non-combustible aerosol provision system to replicate the ‘FMC’ flavour, sensation, or a combination thereof. In particular, the inventors have identified a range of compounds (also called chemical markers) responsible for various flavour dimensions of smoking a cigarette, and identified a combination of such compounds which is particularly beneficial for delivering the desired ‘FMC-like’ flavour experience. The inventors have further identified a range of compounds / chemical markers responsible for the irritation to the mouth, nose and / or throat experienced when smoking a cigarette. These compounds were identified by collecting and analysing a range of different tobacco extracts, as well as using machine learning and / or human sensory assessment. More information on the analysis is set out herein.

[0032] The compounds of the present disclosure can advantageously be present in an aerosolised formulation which replicates the ‘FMC’ flavour and / or irritation experience. Furthermore, the levels of the compounds can be adjusted in order to tailor the flavour and / or irritation intensity to consumer preference or the substrate material (for example, the tobaccotype from which the base extract was derived).

[0033] In total, the inventors identified over 300 compounds across 9 different tobacco extracts, the extracts being obtained by a variety of extraction methods and from various tobacco sources (e.g. Virginia, Oriental, Burley, Dark and combinations thereof). Four of the tobacco extracts were then identified as being particularly appealing to consumers seeking an ‘FMC-like’ experience, and the compounds present in the aerosol generated by these extracts further analysed for chemical markers providing tobacco flavour and / or irritation. Some chemical markers provide both tobacco flavour and irritation, others are limited to one or the other.

[0034] With this assessment, the inventors have found a combination of chemical markers that is able to provide a tobacco aroma and / or irritation when present in an aerosol obtained from a substance delivery system, particularly a non-combustible aerosol provision system, without the need to smoke or burn a cigarette. This includes the ability to combine the combination of chemical markers with a substrate material, such as a tobacco or other plant extract, and thereby improve the ‘FMC-like’ sensorial experience provided by the substrate material when used in a substance delivery system, in the oral cavity of the consumer. This may allow for a more user-friendly and improved cigarette-like experience to be created.

[0035] Several benefits are therefore associated with the aerosolised formulation of the present disclosure; many consumers who smoke traditional cigarettes may previously have been reluctant or unwilling to use non-combustible aerosol provision devices, e.g. heat-not-burn, hybrid or vapour devices, because the experience of using these devices may differ from the experience of burning and smoking a cigarette. The aerosolised formulation of the present disclosure may, however, allow for consumers to get the same or similar experience to smoking a cigarette when using non-combustible aerosol provision systems. For example, a more ‘cigarette-like’ aerosol is possible.

[0036] For ease of reference, these and further aspects of the present invention are now discussed under appropriate section headings. However, the teachings under each section are not necessarily limited to each particular section. In other words, particular sections of the description are not to be read in isolation from other sections.Aerosolised Formulation

[0037] There is provided herein an aerosolised formulation which provides a tobacco aroma (flavour) and / or irritation to the mouth, nose and / or throat and thereby replicates the desired ‘FMC-like’ experience for a consumer. By the term “tobacco aroma” is meant an aroma that simulates the aroma from burning or smoking a cigarette containing tobacco. This aroma results from various volatile compounds naturally-present in the tobacco and / or produced during curing, aging and / or processing of the tobacco leaves. The compounds present in the composition from which the aerosolised formulation of the present disclosure is obtained thus have a boiling point of less than 250°C and / or a molecular weight of about 50 to about 500 g / mol. The molecular weight is the ratio of the mass of a molecule to the unified atomic mass unit (as defined in the IIIPAC Gold Book); it is also referred to in the art as the relative molar mass. It also follows that the compounds present in the composition from which the aerosolised formulation is derived have the potential to be aerosolised when the composition is used in the non-combustible aerosol provision system or device, such as a heat-not-burn or vaping device or system.

[0038] As well as being used in a non-combustible substance delivery system such as a non-combustible aerosol provision system, the composition from which the aerosolised formulation is obtained in the present disclosure is not raw tobacco. As used herein, the term “raw tobacco” refers to any part of a plant of the Nicotiana species (e.g. leaf or stem) that has been harvested from the ground but not otherwise subjected to any processing steps.

[0039] The composition may be used in the non-combustible aerosol provision system with or without a plant (e.g. tobacco) material. When used in combination with a tobacco material such as a tobacco extract, the extract may first be analysed for the presence of one or more of thecompounds that result in the compounds present in the aerosol, and then supplemented with one or more compounds as disclosed herein in order to improve the FMC-like flavour and / or sensation experience obtained when used in the non-combustible aerosol provision system. That is, one or more of the compounds defined herein may be added to a tobacco extract, the tobacco extract optionally already containing one or more of the compounds defined herein.

[0040] It is also possible to add further compounds to the compositions. Such compounds may be absent from a tobacco extract, but present in smoke formed by burning the same tobacco used to form the extract, e.g. in a cigarette. These compounds are discussed further below and termed the ‘smoke markers’. This may, in some examples, further improve the cigarette-like experience provided by the composition of the present disclosure when used in a substance delivery system.Group (a): Irritation Markers

[0041] The aerosolised formulation of the present disclosure includes at least one compound from group (a). Such compounds are irritation markers and they are referred to herein as “the key irritation marker list”. These compounds are also shown in the table below together with their CAS No(s) and chemical structure. As noted above, in all aspects of the present disclosure, the disclosure includes, where appropriate, all enantiomers, tautomers, stereoisomers and geometric isomers of the compounds disclosed herein, as appropriate. Hence, where one enantiomer, tautomer, stereoisomer and / or geometric isomer is depicted or referenced herein, this is not to be construed as limiting. The table below also includes the compound class of each irritation marker.CAS- Chemical structure Compound Compound Name No Class l,6,10,14-hexadecatetraen-3- 1113- Aliphatic ol3,7,ll,15-tetramethyl-,(E,E)- iiiiiii alcohol Substituted pyrazole HN 13-Methyl-lH-pyrazole-4- 112758- carbaldehyde 40-4

[0042] In some examples, the formulation comprises both compounds selected from the key irritation marker list. In some examples the formulation comprises one compound from the key irritation marker list.

[0043] In some examples, the formulation comprises one or more additional irritation markers. Such compounds may be cotinine, myosmine, or a combination thereof. In some examples, the formulation comprises cotinine and myosmine.

[0044] In some examples, the concentration of each irritation marker defined herein in the aerosol is from about 10 ng / puff to about 300 ng / puff. The method for calculating ng / puff is set out in the Examples and applies to all concentrations of compounds in the aerosol disclosed herein.

[0045] In some examples, the concentration of each irritation marker defined herein in the aerosol is from about 15 ng / puff to about 200 ng / puff. In some examples, the concentration of each irritation marker defined herein in the aerosol is from about 20 ng / puff to about 200 ng / puff.

[0046] In some examples, the total concentration of irritation markers defined herein is about 50 ng / puff to about 500 ng / puff. In some examples, the total concentration of irritation markers defined herein in the aerosol is about 75 ng / puff to about 400 ng / puff. In some examples, the total concentration of irritation markers defined herein in the aerosol is about 100 ng / puff to about 300 ng / puff.

[0047] In some examples, the aerosolised formulation comprises 1,6,10-14-hexdecatetraen- 3-ol,3,7,11,15-tetramethyl in an amount of at least about 40 ng / puff. In some examples, the aerosolised formulation comprises 1,6,10-14-hexdecatetraen-3-ol,3,7,11,15-tetramethyl in an amount of at least about 50 ng / puff. In some examples, the aerosolised formulation comprises 1,6,10-14-hexdecatetraen-3-ol,3,7,11,15-tetramethyl in an amount of at least about 60 ng / puff. In such examples, the upper limit of 1, 6, 10-14-hexdecatetraen-3-ol, 3, 7,11,15-tetramethyl in the aerosolised formulation may be about 200 ng / puff.

[0048] In some examples, the aerosolised formulation comprises 3-methyl-1H-pyrazole-4-carbaldehyde in an amount of at least about 0.1 ng / puff. In some examples, the aerosolised formulation comprises 3-methyl-1H-pyrazole-4-carbaldehyde in an amount of at least about 0.25 ng / puff. In some examples, the aerosolised formulation comprises 3-methyl-1H-pyrazole- 4-carbaldehyde in an amount of at least about 0.5 ng / puff. In such examples, the upper limit of 3-methyl-1H-pyrazole-4-carbaldehyde in the aerosolised formulation may be about 10 ng / puff.

[0049] In some examples, the aerosolised formulation comprises myosmine in an amount of at least about 25 ng / puff. In some examples, the aerosolised formulation comprises myosmine in an amount of at least about 40 ng / puff. In some examples, the aerosolised formulation comprises myosmine in an amount of at least about 55 ng / puff. In such examples, the upper limit of myosmine in the aerosolised formulation may be about 200 ng / puff.

[0050] In some examples, the aerosolised formulation comprises cotinine in an amount of at least about 10 ng / puff. In some examples, the aerosolised formulation comprises cotinine in an amount of at least about 15 ng / puff. In some examples, the aerosolised formulation comprises cotinine in an amount of at least about 20 ng / puff. In such examples, the upper limit of cotinine in the aerosolised formulation may be about 200 ng / puff.

[0051] In some examples, the combined amount of myosmine and cotinine in the aerosolised formulation may be at least about 35 ng / puff. In some examples, the combined amount of myosmine and cotinine may be at least about 55 ng / puff. In some examples, the combined amount of myosmine and cotinine may be at least about 75 ng / puff. In such examples, the upper limit of myosmine and cotinine combined may be about 300 ng / puff.

[0052] In some examples, the aerosolised formulation further comprises 6,8-nonadien-2-one, 8-methyl-5-(1 -methylethyl)-. When present, this compound may be in an amount of at least about 10 ng / puff. In some examples, the aerosolised formulation comprises 6,8-nonadien-2-one, 8-methyl-5-(1 -methylethyl)- in an amount of at least about 15 ng / puff. In some examples, the aerosolised formulation comprises 6,8-nonadien-2-one, 8-methyl-5-(1-methylethyl)- in an amount of at least about 10 ng / puff. In such examples, the upper limit may be about 100 ng / puff.

[0053] The skilled person will appreciate that the above concentrations may be combined when the composition includes the named compounds in combination with one another according to the above-described examples.Group (b): Tobacco Flavour Markers

[0054] The aerosolised formulation of the present disclosure includes at least two compounds from group (b). Such compounds are tobacco flavour markers and they are referred to herein as “the key tobacco flavour marker list”. These compounds are also shown in the table below together with their CAS No(s) and chemical structure. As noted above, in all aspects of the present disclosure, the disclosure includes, where appropriate, all enantiomers, tautomers, stereoisomers and geometric isomers of the compounds disclosed herein, as appropriate. Hence, where one enantiomer, tautomer, stereoisomer and / or geometric isomer is depicted or referenced herein, this is not to be construed as limiting. The table below also includes the compound class of each irritation marker.CAS- Chemical structure Chemical Compound Name No Class C7 to C18 aromatic aldehyde Phenylacetaldehyde; 122-78- Benzeneacetaldehyde 1Nonanal; Nonyl 124-19- Aliphatic aldehyde; Aldehyde C-9; 6 aldehyde Ketone2,3-Pentanedione;Acetylpropionyl; 2,3- 600-14- Pentadione 6Aromatic hydrocarbon 108-88- Toluene 3Aromatic hydrocarbon 100-41- Ethylbenzene 4112-40- Aliphatic Dodecane 3 hydrocarbon Ketone6,8-Nonadien-2-one, 8- methyl-5-(l- 54868- methylethyl)-, (E)- 48-3Bipyridine compound581-50- 2,3'-Dipyridyl 0Aliphatic aldehyde 590-86- Butanal, 3-methyl- 3629-59- Aliphatic Tetradecane 4 hydrocarbon 110-62- Aliphatic Pentanal; Valeraldehyde 3 aldehyde C7 to C18 Guaiacol; o- substituted Methoxyphenol; o- phenol Hydroxyanisole; Phenol,2-methoxy- 90-05-1t)0055] In some examples, the formulation comprises at least three compounds selected from the key tobacco flavour marker list. In some examples, the formulation comprises at least four compounds selected from the key tobacco flavour marker list. In some examples, the formulation comprises at least five compounds selected from the key tobacco flavour marker list. In some examples, the formulation comprises at least six compounds selected from the key tobacco flavour marker list.

[0056] In some examples, the formulation comprises all of the compounds selected from the key tobacco flavour marker list.

[0057] In some examples, the formulation comprises at least two compounds selected from phenylacetaldehyde, Nonanal, butanal, 3-methyl-, tetradecane, and pentanal. In some examples, the at least two compounds from group (b) include butanal, 3-methyl-. In some examples, the at least two compounds from group (b) include butanal, 3-methyl- and phenylacetaldehyde. In some examples, the at least two compounds from group (b) include butanal, 3-methyl- and nonanal. In some examples, the at least two compounds from group (b) include butanal, 3-methyl- and tetradecane. In some examples, the at least two compounds from group (b) include butanal, 3-methyl- and pentanal. In any of the above examples, the formulation may further comprise one or more of toluene, ethylbenzene, dodecane, 2,3’-dipyridyl, guaiacol and 1,2-propanediol, 1-acetate. In some examples, the formulation further comprises 2,3’dipyridyl. In some examples, the formulation further comprises 1,2-propanediol, 1-acetate. In some examples, the formulation further comprises guaiacol. In some examples, the formulation further comprises toluene. In some examples, the formulation further comprises ethylbenzene.

[0058] In some examples, the formulation comprises phenylacetylaldehyde, Nonanal, 2,3-pentanedione, toluene, ethylbenzene, dodecane, 6,8-nonadien-2-one, 8-methyl-5-(1-methylethyl)-, 2,3’dipyridyl, butanal, 3-methyl-, 1,2-propanediol, 1-acetate, tetradecane and pentanal. In some examples, the formulation comprises phenylacetylaldehyde, Nonanal, toluene, ethylbenzene, dodecane, 2,3’-dipyridyl, butanal, 3-methyl-, 1,2-propendiol, 1-acetate, tetradecane, pentanal, and guaiacol.

[0059] The skilled person will appreciate that any of the above examples focussed on the group (b) compounds may be combined with the above examples focussed on the group (a) compounds and the other irritation markers. For example, the definitions of group (b) may be combined with group (a) as 1,6,10,14-hexadecatetraene-3-ol,3,7,11,15-tetramethyl-. The definitions of group (b) may be combined with group (a) as 3-methyl- 1H-pyrazole-4-carbaldehyde.

[0060] In some examples, the formulation comprises one or more additional tobacco flavour markers. Such compounds may be cotinine, myosmine, or a combination thereof. In some examples, the formulation comprises cotinine and myosmine. Cotinine and myosmine are markers of both irritation and tobacco flavour in this respect and the concentrations defined above for these compounds apply irrespective of their reason for inclusion.

[0061] In some examples, the additional tobacco flavour markers may be phenethylalcohol, ethanone, 1 -(1 H-pyrrol-2-yl)-, or a combination thereof. In some examples, the additional tobacco flavour markers further comprise acetic acid.

[0062] In some examples, the concentration of each tobacco flavour marker defined herein in the aerosol is from about 1 ng / puff to about 1500 ng / puff. The method for calculating ng / puff is set out in the Examples and applies to all concentrations of compounds in the aerosol disclosed herein. In some examples, the concentration of each tobacco flavour marker defined herein in the aerosol is from about 1 ng / puff to about 1200 ng / puff. In some examples, the concentration of each tobacco flavour marker defined herein in the aerosol is from about 2 ng / puff to about 1050 ng / puff.

[0063] In some examples, the total concentration of tobacco flavour markers defined herein is about 150 ng / puff to about 5000 ng / puff. In some examples, the total concentration of tobacco flavour markers defined herein in the aerosol is about 175 ng / puff to about 4000 ng / puff. In some examples, the total concentration of tobacco flavour defined herein in the aerosol is about 100 ng / puff to about 3000 ng / puff.

[0064] In some examples, the aerosolised formulation comprises phenylacetalaldehyde in an amount of at least about 5 ng / puff. In some examples, the aerosolised formulation comprises phenylacetalaldehyde in an amount of at least about 10 ng / puff. In some examples, the aerosolised formulation comprises phenylacetalaldehyde in an amount of at least about 15 ng / puff. In such examples, the upper limit of phenylacetalaldehyde in the aerosolised formulation may be about 50 ng / puff.

[0065] In some examples, the aerosolised formulation comprises nonanal in an amount of at least about 50 ng / puff. In some examples, the aerosolised formulation comprises nonanal in an amount of at least about 100 ng / puff. In some examples, the aerosolised formulation comprises nonanal in an amount of at least about 150 ng / puff. In such examples, the upper limit of nonanal in the aerosolised formulation may be about 500 ng / puff.

[0066] In some examples, the aerosolised formulation comprises 2,3-pentanedione in an amount of at least about 10 ng / puff. In some examples, the aerosolised formulation comprises 2,3-pentanedione in an amount of at least about 20 ng / puff. In some examples, the aerosolised formulation comprises 2,3-pentanedione in an amount of at least about 25 ng / puff. In such examples, the upper limit of 2,3-pentanedione in the aerosolised formulation may be about 250 ng / puff.

[0067] In some examples, the aerosolised formulation comprises toluene in an amount of at least about 5 ng / puff. In some examples, the aerosolised formulation comprises toluene in an amount of at least about 10 ng / puff. In some examples, the aerosolised formulation comprises toluene in an amount of at least about 15 ng / puff. In such examples, the upper limit of toluene in the aerosolised formulation may be about 50 ng / puff.

[0068] In some examples, the aerosolised formulation comprises ethylbenzene in an amount of at least about 1 ng / puff. In some examples, the aerosolised formulation comprises ethylbenzene in an amount of at least about 5 ng / puff. In some examples, the aerosolised formulation comprises ethylbenzene in an amount of at least about 10 ng / puff. In such examples, the upper limit of toluene in the aerosolised formulation may be about 50 ng / puff.

[0069] In some examples, the aerosolised formulation comprises dodecane in an amount of at least about 100 ng / puff. In some examples, the aerosolised formulation comprises dodecane in an amount of at least about 250 ng / puff. In some examples, the aerosolised formulation comprises dodecane in an amount of at least about 500 ng / puff. In such examples, the upper limit of dodecane in the aerosolised formulation may be about 1500 ng / puff.

[0070] In some examples, the aerosolised formulation comprises 6,8-nonadien-2-one, 8-methyl-5-(1 -methylethyl)-, in an amount of at least about 5 ng / puff. In some examples, the aerosolised formulation comprises 6,8-nonadien-2-one, 8-methyl-5-(1 -methylethyl)-, in an amount of at least about 10 ng / puff. In some examples, the aerosolised formulation comprises 6,8-nonadien-2-one, 8-methyl-5-(1 -methylethyl)-, in an amount of at least about 15 ng / puff. In such examples, the upper limit of 6,8-nonadien-2-one, 8-methyl-5-(1 -methylethyl)-, in the aerosolised formulation may be about 50 ng / puff.

[0071] In some examples, the aerosolised formulation comprises guaiacol in an amount of at least about 0.1 ng / puff. In some examples, the aerosolised formulation comprises guaiacol in an amount of at least about 0.5 ng / puff. In some examples, the aerosolised formulation comprises guaiacol in an amount of at least about 1 ng / puff. In such examples, the upper limit of guaiacol in the aerosolised formulation may be about 10 ng / puff.

[0072] In some examples, the aerosolised formulation comprises 2,3’-dipyridyl in an amount of at least about 5 ng / puff. In some examples, the aerosolised formulation comprises 2,3’-dipyridyl in an amount of at least about 10 ng / puff. In some examples, the aerosolised formulation comprises 2, 3’-dipyridyl in an amount of at least about 15 ng / puff. In such examples, the upper limit of 2,3’-dipyridyl in the aerosolised formulation may be about 100 ng / puff.

[0073] In some examples, the aerosolised formulation comprises butanal, 3-methyl- in an amount of at least about 50 ng / puff. In some examples, the aerosolised formulation comprises butanal, 3-methyl-in an amount of at least about 100 ng / puff. In some examples, the aerosolised formulation comprises butanal, 3-methyl-in an amount of at least about 150 ng / puff. In such examples, the upper limit of butanal, 3-methyl-in the aerosolised formulation may be about 500 ng / puff.

[0074] In some examples, the aerosolised formulation comprises 1,2-propanediol, 1-acetate in an amount of at least about 25 ng / puff. In some examples, the aerosolised formulation comprises 1,2-propanediol, 1-acetate in an amount of at least about 50 ng / puff. In some examples, the aerosolised formulation comprises 1,2-propanediol, 1-acetate in an amount of at least about 75 ng / puff. In such examples, the upper limit of 1,2-propanediol, 1-acetate in the aerosolised formulation may be about 200 ng / puff.

[0075] In some examples, the aerosolised formulation comprises tetradecane in an amount of at least about 100 ng / puff. In some examples, the aerosolised formulation comprises tetradecane in an amount of at least about 150 ng / puff. In some examples, the aerosolisedformulation comprises tetradecane in an amount of at least about 200 ng / puff. In such examples, the upper limit of tetradecane in the aerosolised formulation may be about 1000 ng / puff.

[0076] In some examples, the aerosolised formulation comprises pentanal in an amount of at least about 50 ng / puff. In some examples, the aerosolised formulation comprises pentanal in an amount of at least about 100 ng / puff. In some examples, the aerosolised formulation comprises pentanal in an amount of at least about 150 ng / puff. In such examples, the upper limit of pentanal in the aerosolised formulation may be about 500 ng / puff.

[0077] In some examples, the aerosolised formulation comprises phenethyl alcohol in an amount of at least about 1 ng / puff. In some examples, the aerosolised formulation comprises phenethyl alcohol in an amount of at least about 5 ng / puff. In some examples, the aerosolised formulation comprises phenethyl alcohol in an amount of at least about 8 ng / puff. In such examples, the upper limit of phenethyl alcohol in the aerosolised formulation may be about 50 ng / puff.

[0078] In some examples, the aerosolised formulation comprises acetic acid in an amount of at least about 100 ng / puff. In some examples, the aerosolised formulation comprises acetic acid in an amount of at least about 250 ng / puff. In some examples, the aerosolised formulation comprises acetic acid in an amount of at least about 350 ng / puff. In such examples, the upper limit of acetic acid in the aerosolised formulation may be about 1000 ng / puff.

[0079] In some examples, the aerosolised formulation comprises ethanone, 1-(1H-pyrrol-2-yl)- in an amount of at least about 1 ng / puff. In some examples, the aerosolised formulation comprises ethanone, 1-(1 H-pyrrol-2-yl)- in an amount of at least about 5 ng / puff. In some examples, the aerosolised formulation comprises ethanone, 1-(1 H-pyrrol-2-yl)- in an amount of at least about 8 ng / puff. In such examples, the upper limit of ethanone, 1-(1 H-pyrrol-2-yl)- in the aerosolised formulation may be about 50 ng / puff.

[0080] In some examples, the aerosolised formulation comprises myosmine in an amount of at least about 25 ng / puff. In some examples, the aerosolised formulation comprises myosmine in an amount of at least about 40 ng / puff. In some examples, the aerosolised formulation comprises myosmine in an amount of at least about 55 ng / puff. In such examples, the upper limit of myosmine in the aerosolised formulation may be about 200 ng / puff.

[0081] In some examples, the aerosolised formulation comprises cotinine in an amount of at least about 10 ng / puff. In some examples, the aerosolised formulation comprises cotinine in an amount of at least about 15 ng / puff. In some examples, the aerosolised formulation comprisescotinine in an amount of at least about 20 ng / puff. In such examples, the upper limit of cotinine in the aerosolised formulation may be about 200 ng / puff.

[0082] In some examples, the combined amount of myosmine and cotinine in the aerosolised formulation may be at least about 35 ng / puff. In some examples, the combined amount of myosmine and cotinine may be at least about 55 ng / puff. In some examples, the combined amount of myosmine and cotinine may be at least about 75 ng / puff. In such examples, the upper limit of myosmine and cotinine combined may be about 300 ng / puff.

[0083] The skilled person will appreciate that the above concentrations may be combined when the composition includes the named compounds in combination with one another according to the above-described examples.

[0084] In some examples, the concentration of the compounds from groups (a) and (b) in the formulation is at least about 500 ng / puff. In some examples, the concentration of the compounds from groups (a) and (b) in the formulation is at least about 1000 ng / puff. In some examples, the concentration of the compounds from groups (a) and (b) in the formulation is at least about 1500 ng / puff. The upper limit for the compounds from groups (a) and (b) may be about 5000 ng / puff.Organic Acids

[0085] In some examples, the aerosolised formulation comprises at least one organic acid selected from: isovaleric acid, 3-methylpentanoic acid, phenylacetic acid, valeric acid, levulinic acid, 2-methylvaleric acid, 2-methylbutyric acid, heptanoic acid, isobutyric acid, acetic acid, butryric acid, and combinations thereof. In some examples, the at least one organic acid is selected from: phenylacetic acid, isovaleric acid, heptanoic acid, and combinations thereof. In other examples, the at least one organic acid is selected from: isovaleric acid, 3-methylpentanoic acid, phenylacetic acid, valeric acid, levulinic acid, 2-methylbutyric acid, isobutyric acid, acetic acid, and combinations thereof. In some examples, the at least one organic acid is selected from: isovaleric acid, 3-methylpentanoic acid, valeric acid, levulinic acid, 2-methylbutyric acid, isobutyric acid, acetic acid, and combinations thereof.Composition for use in non-combustible aerosol provision system

[0086] The composition from which the aerosolised formulation is obtained, otherwise described as the composition aerosolised in the non-combustible substance delivery system, may comprise one or more compounds obtained by extraction from a tobacco material. Such compounds may include at least one compound from group (a) and at least two compounds from group (b). Groups (a) and (b) are as defined above.

[0087] In accordance with some aspects of the present disclosure, the composition of the present disclosure includes at least three compounds selected from those listed in the table below. As noted above, in all aspects of the present disclosure, the disclosure includes, where appropriate, all enantiomers, tautomers, stereoisomers and geometric isomers of the compounds disclosed herein, as appropriate. Hence, where one enantiomer, tautomer, stereoisomer and / or geometric isomer is depicted or referenced herein, this is not to be construed as limiting.Propanoic acid, Ketone 2-oxo, methylester 600- 22-6Propanoic acid, o C3 to C24 2-methyl- Carboxylic 79-31- acid 22-Cyclopenten-1- Ketone one, 3-methyl- 2758- 18-1D-Limonene Monoterpene5989- 27-56-Ethyl-5,6- C4 to C18 dihydro-2H- Lactone 19895- pyran-2-one35-3Phenol Phenol 108- 95-2Phenol, 4-ethyl- C7 to C18Substituted 123- Phenol 07-9Propanoic acid C3 to C24Carboxylic 79-09- acid 4OHStyrene Substituted Benzene 100- 42-5Benzene, 1 ,3- Substituted dimethyl- Benzene 108- 38-33-Pyridinol ^OH C6 to C18Substituted 109- Pyridine 00-22,3- OH C7 to C18 Dimethoxyphenol Substituted Phenol 5150- 42-52- 0 Ketone Pentadecanone, 502- 6,10,14- 69-2trimethyl- 2-Cyclopenten-1- Ketone one, 3-ethyl-2- hydroxy- 21835- 01-8t)0088] In some examples, the c Jompo.sitio,n comprises limonene (e.g. D-limonene), and at least two compounds selected from myosmine; nicotyrine; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol, and one or more compounds selected from 3-methyl Pentanoic acid, and cotinine. In some examples, the composition comprises limonene, and at least two compounds selected from myosmine, nicotyrine, 6-ethyl-5,6-dihydro-2H-pyran-2-one, and phenol, and two or more compounds selected from 3-methyl Pentanoic acid, and cotinine. In some examples the composition comprises limonene, and at least two compounds selected from myosmine, nicotyrine, 6-ethyl-5,6-dihydro-2H-pyran-2-one, and phenol, and each of 3-methyl Pentanoic acid, and cotinine.

[0089] In some examples, the composition comprises limonene, and at least three compounds selected from myosmine; nicotyrine; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol, and one or more compounds selected from 3-methyl Pentanoic acid, and cotinine. In some examples, the composition comprises limonene, and at least three compounds selected from myosmine, nicotyrine, 6-ethyl-5,6-dihydro-2H-pyran-2-one, and phenol, and two or more compounds selected from 3-methyl Pentanoic acid, 2-pyrrolidinone and cotinine. In some examples the composition comprises limonene, and at least three compounds selected from myosmine, nicotyrine, 6-ethyl-5,6-dihydro-2H-pyran-2-one, and phenol, and each of 3-methyl Pentanoic acid, and cotinine.

[0090] In some examples, the composition comprises myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol, and one or more compounds selected from 3-methyl Pentanoic acid, and cotinine. In some examples, the composition comprises myosmine;nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol, and two or more compounds selected from 3-methyl Pentanoic acid, 2-pyrrolidinone and cotinine. In some examples, the composition comprises myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; phenol, 3-methyl Pentanoic acid, and cotinine.

[0091] In some examples, the composition comprises limonene; myosmine; and nicotyrine. In some examples, the composition comprises limonene; myosmine; nicotyrine, and one or more compounds selected from 3-methyl Pentanoic acid, and cotinine. In some examples, the composition comprises limonene; myosmine; nicotyrine, and two or more compounds selected from 3-methyl Pentanoic acid, 2-pyrrolidinone and cotinine. In some examples, the composition comprises limonene; myosmine; nicotyrine, and 3-methyl Pentanoic acid.

[0092] In some examples, the composition comprises at least two irritation markers selected from 2,3-dimethoxyphenol; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 3-pyridinol; 6-ethyl-5,6-dihydro-2H-pyran-2-one; propanoic acid; and propanoic acid, 2-oxo-, methyl ester. In some examples, the composition comprises at least three irritation markers selected from 2,3-dimethoxyphenol; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 3-pyridinol; 6-ethyl-5,6-dihydro-2H-pyran-2-one; propanoic acid; and propanoic acid, 2-oxo, -methyl ester. In some examples, the composition comprises at least four irritation markers selected from 2,3-dimethoxyphenol; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 3-pyridinol; 6-ethyl-5,6-dihydro-2H-pyran-2-one; propanoic acid; and propanoic acid, 2-oxo-, methyl ester. In some examples, the composition comprises at least five irritation markers selected from 2,3-dimethoxyphenol; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 3-pyridinol; 6-ethyl-5,6-dihydro-2H-pyran-2-one; propanoic acid; and propanoic acid, 2-oxo-, methyl ester. In some examples, the composition comprises 2,3-dimethoxyphenol; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 3-pyridinol; 6-ethyl-5,6-dihydro-2H-pyran-2-one; propanoic acid; and propanoic acid, 2-oxo-, methyl ester. In all of the above examples, the extract composition may further comprise myosmine, nicotyrine, and / or phenol.

[0093] In some examples, the concentration of each irritation marker defined herein in the composition is from about 1 ng / uL to about 300 ng / uL. In some examples, the concentration of each irritation marker defined herein in the composition is from about 5 ng / uL to about 300 ng / uL. In some examples the total concentration of irritation markers defined herein in the composition is from about 500 to about 2000 ng / uL.

[0094] In some examples, the concentration of limonene in the composition is from about 1 ng / uL to about 50 ng / uL. In some examples, the concentration of limonene in the composition is from about 1 ng / uL to about 25 ng / uL. In some examples, the concentration of limonene in the composition is from about 5 ng / uL to about 15 ng / uL.

[0095] In some examples, the composition comprises myosmine and the concentration of myosmine in the composition is from about 1 ng / uL to about 250 ng / uL. In some examples, the concentration of myosmine in the composition is from about 10 ng / uL to about 200 ng / uL. In some examples, the concentration of myosmine in the composition is from about 25 ng / uL to about 150 ng / uL.

[0096] In some examples, the composition comprises nicotyrine and the concentration of nicotyrine in the composition is from about 1 ng / uL to about 250 ng / uL. In some examples, the concentration of nicotyrine in the composition is from about 10 ng / uL to about 200 ng / uL. In some examples, the concentration of nicotyrine in the composition is from about 25 ng / uL to about 150 ng / uL.

[0097] In some examples, the composition comprises 6-ethyl-5,6-dihydro-2H-pyran-2-one and the concentration of 6-ethyl-5,6-dihydro-2H-pyran-2-one in the composition is from about 1 ng / uL to about 250 ng / uL. In some examples, the concentration of 6-ethyl-5,6-dihydro-2H-pyran-2-one in the composition is from about 10 ng / uL to about 200 ng / uL. In some examples, the concentration of 6-ethyl-5,6-dihydro-2H-pyran-2-one in the composition is from about 25 ng / uL to about 150 ng / uL.

[0098] In some examples, the composition comprises phenol and the concentration of phenol in the composition is from about 1 ng / uL to about 150 ng / uL. In some examples, the concentration of phenol in the composition is from about 1 ng / uL to about 100 ng / uL. In some examples, the concentration of phenol in the composition is from about 5 ng / uL to about 50 ng / uL.

[0099] The skilled person will appreciate that the above concentrations may be combined when the composition includes the named compounds in combination with one another according to the above-described examples.[000100] When incorporated into a consumable, e.g. for aerosolisation, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly relative to the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. The concentration values ng / uL may be converted into wt%, based on the total weight of the consumable, as follows:g / mL = ng / uL x 10'6% w / w compound in composition = (g / mL / (composition density in g / mL) x 100)% w / w compound in consumable = (% w / w of compound in composition) I wt% composition in consumable (e.g. 5, 8, 10, 15, 20, 25 and 30 wt%)[000101] In accordance with some aspects of the present disclosure, the composition may be defined as one which comprises at least three compounds from those listed below. As noted above, in all aspects of the present disclosure, the disclosure includes, where appropriate, all enantiomers, tautomers, stereoisomers and geometric isomers of the compounds disclosed herein, as appropriate. Hence, where one enantiomer, tautomer, stereoisomer and / or geometric isomer is depicted or referenced herein, this is not to be construed as limiting.[000102] In some examples, the composition comprises at least three compounds selected from: methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; and Methylacetophenone.[000103] In some examples, the composition comprises at least three compounds selected from: Phenylacetaldehyde; Anisaldehyde; Nonanal; Ethylguaiacol; alpha-Linolenic acid; and Eucalyptol.[000104] In some examples, the composition comprises at least three compounds selected from: Isovaleric acid; 2,3-Pentanedione; Hexanal; Methoxyvinylphenol; Linalool; and Piperitone.[000105] In some examples, the composition comprises at least three compounds selected from: Guaiacol; Terpineol; Methylbutyric acid; Piperonal; indole; and ethyl vanillin.[000106] In some examples, the composition comprises at least three compounds selected from: vanillin; Methylacetophenone; Phenylacetaldehyde; Anisaldehyde; Nonanal; and Ethylguaiacol.[000107] In some examples, the composition comprises at least three compounds selected from: alpha-Linolenic acid; Eucalyptol; Isovaleric acid; 2,3-Pentanedione; Hexanal; and Methoxyvinylphenol.[000108] In some examples, the composition comprises at least three compounds selected from: Linalool; Piperitone; Guaiacol; Terpineol; methylbutyric acid; and Piperonal.[000109] In some examples, the composition comprises at least three compounds selected from: indole; ethyl vanillin; vanillin; methylacetophenone; Phenylacetaldehyde; and anisaldehyde.[000110] In some examples, the composition comprises at least three compounds selected from Nonanal; Ethylguaiacol; alpha-linolenic acid; eucalyptol; isovaleric acid; and 2,3-pentanedione.[000111] In some examples, the composition comprises at least three compounds selected from: Hexanal; Methoxyvinylphenol; Linalool; Piperitone; Guaiacol; and Terpineol.[000112] In some examples, the composition comprises guaiacol.[000113] In some examples, the composition comprises at least one compound selected from: methylbutyric acid; piperonal; indole; methoacetophenone; phenylacetaldehyde; anisaldehyde; nonanal; ethylguaiacol; alpha-linolenic acid; eucalyptol; isovaleric acid; 2,3-pentanedione; hexanal; methoxyvinylphenol; linalool; piperitone; guaiacol; and terpineol.[000114] In some examples, the composition comprises at least three compounds selected from phenylacetaldehyde, methylbutyric acid, isovaleric acid, indole, and guaiacol. In some examples, the composition comprises at least three compounds selected from methylbutyric acid, isovaleric acid, methylacetophenone, guaiacol, and linolenic acid. In some examples, the extract composition comprises at least four compounds selected from methylbutyric acid, isovaleric acid, methylacetophenone, guaiacol, and linolenic acid.[000115] In some examples, the composition further comprises one or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. Such compounds may be considered as additional tobacco flavour markers.[000116] In some examples, the composition comprises at least three compounds selected from indole; alpha-linolenic acid; methoxyvinylphenol; and guaiacol. In some examples, the composition comprises indole; alpha-linolenic acid and methoxyvinyl phenol. In some examples, the composition comprises indole; alpha-linolenic acid, and guaiacol. In some examples, the composition comprises alpha-linolenic acid, methoxyvinylphenol and guaiacol. In some examples, the composition comprises indole, methoxyvinylphenol, and guaiacol.[000117] In some examples, the composition comprises alpha-linolenic acid. The concentration of alpha-linolenic acid in the composition may be about 2 ng / uL to about 300 ng / uL. In some examples, the concentration of alpha-linolenic acid in the composition is about 2 to about 100 ng / uL. In some examples, the concentration of alpha-linolenic acid in the composition is about 2 to about 50 ng / uL.[000118] In some examples, the composition comprises 2-furancarboxyaldehyde, 5-methyl-. The concentration of 2-furancarboxyaldehyde, 5-methyl- in the composition may be about 2 ng / uL to about 300 ng / uL. In some examples, the concentration of 2-furancarboxyaldehyde, 5-methyl- in the composition is about 10 to about 75 ng / uL. In some examples, the concentration of 2-furancarboxyaldehyde, 5-methyl- in the composition is about 10 to about 50 ng / uL.[000119] In some examples, the composition comprises indole. The concentration of indole in the composition may be from about 2 ng / uL to about 150 ng / uL. In some examples, the concentration of indole in the composition is about 2 to about 100 ng / uL. In some examples, the concentration of indole in the composition is about 10 to about 75 ng / uL.[000120] In some examples, the composition comprises methoxyvinylphenol. The concentration of methoxyvinylphenol in the composition may be from about 2 ng / uL to about1150 ng / uL. In some examples, the concentration of methoxyvinylphenol in the composition is about 2 to about 100 ng / uL. In some examples, the concentration of methoxyvinylphenol in the composition is about 5 to about 75 ng / uL.[000121] In some examples, the composition comprises guaiacol. The concentration of guaiacol in the composition may be from about 1 ng / uL to about 100 ng / uL. In some examples, the concentration of guaiacol in the composition is about 1 to about 75 ng / uL. In some examples, the concentration of guaiacol in the composition is about 5 to about 75 ng / uL.[000122] When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly relative to the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. The concentration values ng / uL may be converted into wt%, based on the total weight of the consumable, as follows:g / mL = ng / uL x 10'6% w / w compound in composition = (g / mL I (composition density in g / mL) x 100)% w / w compound in consumable = (% w / w of compound in composition) I wt% composition in consumable (e.g. 5, 8, 10, 15, 20, 25 and 30 wt%)Plant Extracts[000123] In some examples, one or more of the compounds are obtained by extraction from a natural source, e.g. a tobacco source. Also provided herein is a method for forming the composition, the method comprising contacting a tobacco material with a solvent, and extracting one or more of the compounds from the tobacco into the solvent.[000124] The present disclosure is not, however, limited to obtaining one or more compounds via an extraction method. The present disclosure includes the formulation of a partially or totally synthetic or artificial composition. In some examples, at least one of the compounds may be a synthetic compound. In this manner, the composition may include one or more compounds which are naturally derived, e.g. from a tobacco source, and one or more compounds which are synthetic (e.g. obtained commercially or otherwise synthesised).[000125] In some examples, the total number of chemical compounds present in the composition is less than about 800, such as less than about 600, or less than about 500. By total number of chemical compounds is meant the number of different chemical compounds present at a detectable level by e.g. GC-MS.[000126] In some examples, the total content of any one of the tobacco-specific nitrosamines (TSNAs) in the composition, namely N-nitrosonornicotine (NNN), N’-nitrosoanatabine (NAT), N-nitrosoanabasine (NAB) and nicotine-derived nitrosamine ketone (NNK), is less than about 4 pg / g. This may be an indication that at least one compound is obtained from a tobacco extract.[000127] In some examples, the composition may include formaldehyde and / or acetaldehyde. This may be an indication that at least one compound is obtained from a tobacco extract. The amount of formaldehyde and / or acetaldehyde is less than about 4 pg / g.[000128] In some examples, the composition may include at least one plant material, optionally wherein the plant material is a tobacco extract. The tobacco extract may include one or more of the compounds defined above for the composition. The disclosures made herein in relation to the compounds thus apply equally to a tobacco extract comprising one or more of said compounds. In other examples, one or more of said compounds may be added to the tobacco extract to form a composition of the present disclosure. In some examples, the composition is a tobacco extract.[000129] When present or used to obtain one or more compounds of the composition, any tobacco extract may be used. In some examples, the tobacco extract may be an extract of Virginia tobacco, Burley tobacco, Oriental tobacco, Dark tobacco, or a combination thereof. In some examples, the tobacco extract comprises an extract of Virginia tobacco. The tobacco may be cured; in some examples, the tobacco is cured. Cured tobacco may be flue-cured, air-cured and / or sun-cured. In some examples, the tobacco extract comprises an extract of flue-cured Virginia tobacco.[000130] In some examples, the tobacco from which one or more compounds may be extracted (referred to herein as raw tobacco) may include tobacco leaf. In some examples, the tobacco leaf may be defined by its nicotine content. In some examples, the nicotine content of the tobacco leaf may be from about 0.5 to about 8.0 wt%, based on the total weight of the leaf. In some examples, the nicotine content of the tobacco leaf may be from about 0.8 to about 7.5 wt%, based on the total weight of the leaf. In some examples, the nicotine content of the tobacco leaf may be from about 1.5 to about 7.5 wt%, based on the total weight of the leaf.[000131] In some examples, the tobacco leaf may be defined by its sugar content. Exemplary nicotine and sugar contents for flue-cured Virginia tobacco are about 0.9 to about 5.5 wt% nicotine and about 4 to about 25 wt% sugar. Exemplary nicotine and sugar contents for aircured Burley tobacco are about 1.5 to about 6.5 wt% nicotine and less than about 1 to about 2 wt% sugar. Exemplary nicotine and sugar contents for sun-cured Oriental tobacco are about 0.5to about 3.0 wt% nicotine and about 8 to about 12 wt% sugar. Exemplary nicotine and sugar contents for fire-cured dark tobacco are about 2.5 to about 6 wt% nicotine and less than about 1 to about 2 wt% sugar.[000132] In some examples, the tobacco extract is obtained from cured Virginia tobacco, cured Burley tobacco, cured Oriental tobacco, cured Dark tobacco, or a combination thereof. In some examples, the tobacco extract is obtained from flue-cured Virginia tobacco, air-cured Burley tobacco, sun-cured Oriental tobacco, fire-cured Dark tobacco, or a combination thereof.[000133] The solvent extraction method disclosed herein for forming the composition is not particularly limited. It may be a simultaneous distillation extraction method, a supercritical fluid extraction method or a combination thereof. Other extraction methods are also known including maceration or percolation or hot reflux or Soxhlet extraction, or microwave extraction. The method may also include further steps such as filtration, fractionation, pyrolysis, adsorption, distillation and / or purification. Extraction methods are provided in WO 2026 / 021165 A1, US 2026 / 0053181 A1 , WO 2026 / 026620 A1 , WO 2026 / 045589 A1 , and WO 2026 / 045587 A1 which are herein incorporated by reference for such methods.[000134] Hot reflux and microwave extraction are described in WO 2026 / 045589 A1 and WO 2026 / 045587 A1 (Shenzhen Smoore Technology LTD), which are herein incorporated by reference for such methods. For example, a hot reflux extraction method is disclosed using an SF-2L small-scale reflux apparatus. In this method, tobacco leaves are placed in a round-bottom flask which is heated by an electric heating mantle. Evaporated ethanol and water are passed into a condenser and refluxed. The extraction temperature is 95°C and the extraction time is 120 minutes. After extraction, a filtrate is collected and the extract is concentrated using a rotary evaporator. Further examples of hot reflux extraction can be found in WO 2026 / 045587 A1.[000135] Simultaneous distillation extraction is a technique in which the steps of isolation and extraction of certain compounds from a sample can be achieved simultaneously. In some example, a simultaneous distillation extraction (SDE) process can be used for forming tobacco extracts in which process comprises (i) providing a tobacco material, (ii) subjecting the tobacco material to steam distillation, and (iii) extracting one or more volatile compounds of interest from the tobacco material with a solvent, wherein the distillation step (ii) and extraction step (iii) are carried out simultaneously.[000136] The method may comprise mixing a quantity of tobacco (e.g. ground tobacco) with water. This solution may have a pH of from about 5 to about 7, such as from about 5.5 to about6.5. Glass beads may be added to prevent bumping. The solution may then be heated, for example, to a temperature of from about 100°C to about 130°C.[000137] The distillation step (ii) and extraction step (iii) being carried out simultaneously means that in some examples, the SDE method may be carried out in a single step. In some examples, an additional distillation and / or extraction step is excluded. In some examples, the SDE method is carried out in a single apparatus with no additional processing prior to removal of the extracted product from the apparatus.[000138] In some examples the solvent used for extraction is a non-polar solvent. In some examples the solvent used for extraction is a polar solvent. As used herein, the term “polar” refers to a solvent having a dielectric constant of greater than or equal to 15. As used herein, the term “non-polar” refers to a solvent having a dielectric constant of less than 15.[000139] In some examples, the solvent is immiscible with water. In some examples, the solvent comprises an organic solvent. The term “organic” is understood in the art; it is typically considered to be a solvent comprising carbon. In some examples, the solvent is selected from: n-butanol, cyclohexane, dichloromethane, ethyl acetate, heptane, hexane, methyl-t-butyl ether, 2-butanone, pentane, diisopropyl ether, diethyl ether, and mixtures thereof. The use of a mixture of pentane and ether is non-toxic and may be easily replaced by ethanol after extraction of the volatile compounds of interest has been achieved.[000140] In some examples, further processing of the extracted product may be carried out. The further processing may comprise a purifying step which comprises replacing the solvent used for extraction with another solvent suitable for use in a composition as described herein. In some examples, such a purifying step comprises replacing the solvent used for extraction with ethanol.[000141] In some examples a supercritical fluid extraction (SFE) process used for forming tobacco extracts is employed. The process may comprise contacting tobacco with an extraction solvent under supercritical conditions. In some examples, the extraction solvent comprises, or is, supercritical carbon dioxide. In some examples, no co-solvent is present.[000142] In some examples, the SFE process is performed at a pressure of from about 50 to about 500 bar. In some examples, the temperature during extraction may range from about 25°C to about 90°C. In some examples, supercritical extraction is performed using a flow rate of extraction solvent of from about 0.5 to about 5 kg / hr. In some examples, the pressure is varied during the SFE process, for example to collect fractions having varying volatility. In such examples, a lower pressure (e.g. about 50 to about 200 bar) may be used for a first period oftime, followed by a higher pressure (e.g. from about 200 to about 500 bar) for a second period of time. The first period of time may be from about 0.5 to about 2 hours. The second period of time may be from about 0.5 to about 2 hours. In some examples, the two fractions or extracts are combined. In some examples the two fractions or extracts are collected separately and not combined. In some examples, only the extract from the second extraction is retained and / or used in the present disclosure.[000143] In some examples, the SFE process involves placing ground tobacco into a vessel (e.g. 260 g of ground tobacco into a 1L vessel) and using supercritical carbon dioxide as the extraction solvent at 1 kg / h. No co-solvent may be used. The pressure of the system is set to 100 to 300 bar and the temperature maintained at 60 degrees. The extracts are collected in two containers: one for the volatile fraction, one for the non-volatile fraction. The volatile fraction is collected first, pressure at 100 bar and for a period of 1 hour. The non-volatile fraction is collected second, the pressure being increased to 300 bar and extraction conducted for a period of 1.5 hours. Only the non-volatile fraction is retained for the present disclosure.[000144] In some examples, the SFE process involves placing ground tobacco in a container (e.g., 260 g of ground tobacco in a 1 L container) and using supercritical carbon dioxide as an extraction solvent at 1 kg / h and ethanol as a co-solvent (30%). The pressure of the system is set to 250 bar and the temperature maintained at 75 degrees. The extracts are collected for a period of 2 hours.[000145] In accordance with some aspects of the present disclosure, there is provided a composition for a substance delivery system, wherein the composition comprises a plant extract as defined herein, limonene, and at least one compound from the combined list of key irritation markers and key tobacco flavour markers; namely myosmine; p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6, 10, 14-trimethyl-; 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-; methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; Methylacetophenone; Phenylacetaldehyde; Anisaldehyde; Nonanal; Ethylguaiacol; alpha-Linolenic acid; Eucalyptol; Isovaleric acid; 2,3-Pentanedione; Hexanal; Methoxyvinylphenol; Linalool; Piperitone; Guaiacol; and Terpineol.[000146] In accordance with some aspects of the present disclosure, there is provided a composition for a substance delivery system, wherein the composition comprises a plant extract as defined herein, guaiacol, and at least one compound from the combined list of key irritationmarkers and key tobacco flavour markers; namely myosmine; limonene, p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6,10,14-trimethyl-; 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-; methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; Methylacetophenone; Phenylacetaldehyde; Anisaldehyde; Nonanal; Ethylguaiacol; alpha-Linolenic acid; Eucalyptol; Isovaleric acid; 2,3-Pentanedione; Hexanal; Methoxyvinylphenol; Linalool; Piperitone; and Terpineol.[000147] In some examples, the composition comprises at least two of the listed compounds. In some examples, the composition comprises at least three of the listed compounds. In some examples, the composition comprises at least four of the listed compounds. In some examples, the composition comprises at least five of the listed compounds. In some examples, the composition comprises at least six of the listed compounds. In some examples, the composition comprises at least seven of the listed compounds. In some examples, the composition comprises at least eight of the listed compounds. In some examples, the composition comprises at least nine of the listed compounds. In some examples, the composition comprises at least ten of the listed compounds.[000148] In some examples, the composition comprises the key irritation markers as defined above.[000149] In some examples, the composition comprises the key tobacco flavour markers as defined above.[000150] In some examples, the composition comprises limonene and / or guaiacol, and at least one compound selected from: myosmine; nicotyrine; 6-ethyl-5,6-dihydro-2H-pyran-2-one, phenol; indole; alpha-linolenic acid; and methoxyvinylphenol. In some examples, the composition comprises limonene and / or guaiacol, and at least two compounds selected from: myosmine; nicotyrine; 6-ethyl-5,6-dihydro-2H-pyran-2-one, phenol; indole; alpha-linolenic acid; and methoxyvinylphenol. In some examples, the composition comprises limonene and / or guaiacol, and at least three compounds selected from: myosmine; nicotyrine; 6-ethyl-5,6-dihydro-2H-pyran-2-one, phenol; indole; alpha-linolenic acid; methoxyvinylphenol. In some examples, the composition comprises limonene and / or guaiacol, and at least four compounds selected from: myosmine; nicotyrine; 6-ethyl-5,6-dihydro-2H-pyran-2-one, phenol; indole; alpha-linolenic acid; methoxyvinylphenol. In some examples, the composition comprises limonene and / or guaiacol, and at least five compounds selected from: myosmine; nicotyrine; 6-ethyl-5,6-dihydro-2H-pyran-2-one, phenol; indole; alpha-linolenic acid; methoxyvinylphenol. In some examples, the composition comprises limonene and / or guaiacol, and at least six compounds selected from: myosmine; nicotyrine; 6-ethyl-5,6-dihydro-2H-pyran-2-one, phenol; indole; alpha-linolenic acid; methoxyvinylphenol. In some examples, the composition comprises limonene and / or guaiacol and each of myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one, phenol; indole; alpha-linolenic acid; methoxyvinylphenol.[000151] Further combinations of markers applicable for all compositions of the present disclosure are disclosed below.[000152] In some examples, the composition comprises limonene and at least two compounds selected from myosmine; nicotyrine; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol, and at least one compound selected from: methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; Methylacetophenone; Phenylacetaldehyde; Anisaldehyde; Nonanal; Ethylguaiacol; alpha-Linolenic acid; Eucalyptol; Isovaleric acid; 2,3-Pentanedione; Hexanal; Methoxyvinylphenol; Linalool; Piperitone; Guaiacol; and Terpineol. In some examples, the at least one compound is selected from indole, alpha-linolenic acid, methoxyvinylphenol, and guaiacol.[000153] In some examples, the composition comprises limonene; myosmine; and nicotyrine, and at least one compound selected from: methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; Methylacetophenone; Phenylacetaldehyde; Anisaldehyde; Nonanal; Ethylguaiacol; alpha-Linolenic acid; Eucalyptol; Isovaleric acid; 2,3-Pentanedione; Hexanal; Methoxyvinylphenol; Linalool; Piperitone; Guaiacol; and Terpineol. In some examples, the at least one compound is selected from indole, alpha-linolenic acid, methoxyvinylphenol, and guaiacol.[000154] In some examples, the composition comprises alpha-linolenic acid; methoxyvinyl phenol; and guaiacol; and at least one compound selected from: myosmine; p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; Limonene; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6, 10, 14-trimethyl-; and 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-. In some examples, the at least one compound is selected from myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol. In some examples, the at least one compound is limonene.[000155] In some examples, the composition comprises alpha-linolenic acid; methoxyphenol; and guaiacol; and at least one compound selected from: myosmine; p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; Limonene; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6, 10, 14-trimethyl-; and 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-. In some examples, the at least one compound is selected from myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol. In some examples, the at least one compound is limonene.[000156] In some examples, the composition comprises alpha-linolenic acid; and guaiacol; and at least one compound selected from: myosmine; p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; Limonene; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6, 10,14-trimethyl-; and 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-. In some examples, the at least one compound is selected from myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol. In some examples, the at least one compound is limonene.[000157] In any of the above examples, the composition may further comprise one or more compounds selected from 3-methyl Pentanoic acid and cotinine. Such compounds may be considered as additional irritation markers. In some examples, the composition further comprises two or more compounds selected from 3-methyl Pentanoic acid, 2-pyrrolidinone and cotinine. In some examples the composition further comprises 3-methyl Pentanoic acid.[000158] In any of the above examples, the composition may further comprise one or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone, 5,6,7, 7a-tetrahydro-4, 4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. Such compounds may be considered as additional tobacco flavour markers.Tobacco Particles[000159] In some examples, the composition may further comprise a plurality of solid tobacco particles. In some examples, the solid tobacco particles remain as distinct entities within the composition, such that the composition can be considered to be in the form of a heterogeneous mixture. For example, the solid tobacco particles may be at least partially suspended in thecomposition. As used herein, the term “at least partially suspended” means that the solid tobacco particles are distributed within the composition (e.g. a liquid composition), wherein the distribution of said particles within the formulation is not necessarily even. For example, the spatial distribution of the particles may be biased towards one portion of the composition. In some examples, the suspension of the particles may be enhanced by agitation, for example shaking or inversion, such as when comprised in an article and / or in a non-combustible aerosol provision system, including in use.[000160] In some examples the solid tobacco particles are visible, for example to the naked eye. It will be understood that the term “visible” as used herein means that the solid tobacco particles can be seen, e.g. when present in a composition according to the present disclosure, such as by a user. Thus, the presence of the solid tobacco particles in the composition of the present disclosure can be readily apparent to a user (e.g. of a substance provision system), such as by the presence of distinct, visible particles in said composition. By “the naked eye”, the term will be understood to mean that the solid tobacco particles can be seen e.g. by a user without magnification or other visual enhancement. In various examples, the solid tobacco particles are visible under ambient conditions, for example normal temperature (e.g. from about 15 °C to about 25 °C) and pressure (e.g. about 1 atm). In various examples, the tobacco particles may be visible in one or more stages of use but not all. For example, the tobacco particles may be visible in the composition as such. In further examples, the tobacco particles may be visible when the composition is comprised in an article. For example, the article may be partially or completely transparent such that the presence of the tobacco particles in the formulation in the article may be determined by a user by viewing the article. In some examples, the article may comprise at least a transparent portion, wherein the transparent portion may be configured so that the solid tobacco particles are visible to the naked eye, e.g. to a user of the article. In further examples, the tobacco particles may be visible when the composition is comprised in a substance delivery system. For example, the article and substance delivery system may each comprise at least a transparent portion wherein said transparent portions are arranged such that the tobacco particles are visible to the naked eye, e.g. to a user of the substance delivery system.[000161] The size of the solid tobacco particles is not necessarily limited. In some examples, the solid tobacco particles have a size of at least about 50 pm, at least about 0.1 mm or at least about 0.5 mm. In some examples, the solid tobacco particles have a size of up to about 15 mm, up to about 10 mm or up to about 2 mm. In further examples, the solid tobacco particles have a size of from about 50 pm to about 15 mm, from about 0.1 mm to about 10 mm or from about 0.5 mm to about 2 mm. The particle size may be determined by sieving. For example, a recitedlower particle size limit means that the particles will not pass through a sieve with a mesh size of said limit, and an upper particle size limit means that the particles will pass through a sieve with a mesh size of said limit. Thus, a particle size of at least 50 pm means that the particles are retained on a sieve with a 50 pm mesh. In another example, a particle size of up to about 15 mm means that the particles are not retained on a sieve (i.e. the particles pass through the sieve) with a 15 mm mesh.[000162] In some examples, at least about 80%, at least about 90%, at least about 95% or at least about 99% by weight of the solid tobacco particles have a size according to any of the foregoing examples.[000163] The tobacco material from which the tobacco particles according to the present disclosure are obtained or obtainable from is not necessarily limited. For example, the tobacco material may be as described in any of the examples of tobacco / tobacco material described herein. In some examples, the tobacco material from which the tobacco particles are obtained or obtainable from may include tobacco leaf. In further examples the tobacco leaf may be defined by its nicotine and / or sugar content as described herein.[000164] In some examples, the tobacco particles are obtained or obtainable by grinding a tobacco material, such as tobacco leaf. The means by which the tobacco material may be ground is not limited and a person of skill in the art of the present disclosure will be able to select suitable apparatus and / or methods for grinding a tobacco material such as tobacco leaf as part of their common general knowledge. In some examples, the tobacco particles are obtained or obtainable by mill grinding a tobacco material. For instance, using a cutting mill, examples of which are commercially available and known to a person of skill in the art. For instance, a FRITSCH PULVERISETTE 19 cutting mill. In some examples, tobacco particles are obtained or obtainable by grinding, such as mill grinding, a tobacco material and sieving the ground tobacco material, e.g. to obtain a particle size such as those disclosed herein. In some examples the sieving may be integrated into the grinding process, e.g. the grinding apparatus such as a cutting mill may comprise a sieve.[000165] In some examples, the tobacco material from which the tobacco particles are obtained may have been processed. In some examples, the tobacco particles may be obtained or obtainable from a tobacco material that has been extracted with at least one solvent. For example, a waste or by-product of an extraction process such as disclosed in further detail herein. In advantageous examples, the tobacco material may have been ground, e.g. to form solid tobacco particles, prior to the extraction process such that the solid tobacco particles may be used directly after the extraction process in the composition of the present disclosure.Other Compounds[000166] The composition of the present disclosure may include one or more other compounds as defined below. These compounds are understood to be in addition to any compounds of the named classes present as tobacco flavour / irritation markers as defined herein.[000167] In some examples, the composition includes at least one C6 to C18 substituted pyrazine. In some examples the C6 to C18 substituted pyrazine comprises substituents selected from alkyl groups, alkenyl groups, aryl groups, hydroxyl groups, carboxyl groups, alkoxy groups, sulfhydryl groups, thionyl groups, sulfide groups, and combinations thereof. The alkyl groups are preferably C1 to C6 alkyl groups; the alkenyl groups are preferably C2 to C6 alkenyl groups; and the carboxyl groups are preferably ketones or aldehydes such as C2 to C6 ketones. The at least one C6 to C18 substituted pyrazine may be selected from pyrazine, trimethyl- (e.g. 2,3,5-trimethylpyrazine); pyrazine, 2,6-diethyl; pyrazine, tetramethyl- (e.g. 2, 3,5,6-tetramethylpyrazine); 2-methylpyrazine; 2,3-dimethylpyrazine; 2,5-dimethyl pyrazine; 2-ethylpyrazine; isopropenylpyrazine; acetyl pyrazine; 2-ethyl-6-methylpyrazine; 2-methoxy-3-methylpyrazine; 2,3-diethylpyrazine, 2-methyl-3-methylsulfanylpyrazine; 1-pyrazin-2-ylethanone; cyclohexylmethylpyrazine; deoxyfructosazine; and combinations thereof.[000168] In some examples, the composition includes a terpene alcohol which may be selected from geranyl linalool, isophytol, menthol, dihydrolinalool, phytol, sclareol, 2-[5-methyl-5-vinyltetrahydro-2-furanyl]-2-propanol, a b 2,7,11 Cembratrienodiol 4,6 diol, labdenediol, nerolidol, and combinations thereof.[000169] In some examples, the composition comprises at least one C7 to C18 aromatic acetal which may be present as a key tobacco flavour marker) optionally selected from veratraldehyde propylene glycol acetal, 2-phenyl,1,3-dioxan-5-ol, 4-methyl-2-phenyl-1,3-dioxolane, 2-(4-methoxyphenyl)-4-methyl-1,3-dioxolane, and combinations thereof.[000170] In some examples, the composition comprises at least one C3 to C24 carboxylic acid which is optionally selected from benzoic acid, phenylacetic acid, and anhydrides thereof, or C5 to C24 fatty acids.[000171] In some examples, the composition comprises one or more C6 to C24 aliphatic esters which are optionally fatty acid esters selected from: ethyl butyrate, methyl butyrate, methyl hexanoate, ethyl hexanoate, methyl octanoate, ethyl octanoate, methyl decanoate, ethyl decanoate, methyl laurate, ethyl laurate, methyl tetradecanote, ethyl tetradecanoate, methyl palmitate, ethyl pentadecanoate, ethyl palmitate, methyl linoleate, ethyl linolenate, ethyllinoleate, methyl stearate, ethyl stearate, methyl linolenate, docosahexanoic acid methyl ester, methyl pyruvate, ethyl pyruvate, and combinations thereof.[000172] In some examples, the composition comprises at least one C4 to C18 lactone which is optionally selected from valerolactone, undecan-4-olide, dihydroactinidiolide, delta- Decalactone, sclareolide, butyrolactone, but-2-en-4-olide, caprolactone, dl-pantolactone, gamma-octanoic lactone, gamma-nonalactone, alpha-levantanolide, 6-pentyloxan-2-one, gamma-decanolactone, (2,6,6-trimethyl-2-hydroxycyclohexylidene)acetic acid lactone, dodecalactone, loliolide, 5-methoxypsoralen, 6-methoxyfuro[2,3-h]chromen-2-one, 3,4-dihydroisocoumarin, maltol (3-Hydroxy-2-methyl-4H-pyran-4-one), 2,3-dihydro-3,5-dihydroxy-6-methyl-4(h)-pyran-4-one, ethyl maltol (2-Ethyl-3-hydroxy-4H-pyran-4-one), coumarin, 3,4-dihydrocoumarin, 6-methylcoumarin, 6-hydroxy-4-methylcoumarin, 7-hydroxycoumarin, 7-ethoxycoumarin, scopoletin, esculetin, 3-amino-4,7-dihydroxycoumarin, 6-Ethyl-5,6-dihydro-2H-pyran-2-one, pantolactone,, and combinations thereof.[000173] In some examples, the composition may further comprise a bipyridine compound, optionally which is 2,3’-dipyridyl or4,4'-Methylenedipyridine. In some examples, the composition may be substantially free from bipyridine compounds.[000174] In some examples the composition may comprise at least one norisoprenoid. In some examples the at least one norisoprenoid is selected from damascenone, damascene, ionone, megastigmatrienone, n-methylionone, solanone, 3-hydroxy-beta-damascone, 3-buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl), or a combination thereof.[000175] In some examples, the composition may comprise nicotine.[000176] In some examples, the composition further comprises at least one norisoprenoid and nicotine, optionally wherein the weight ratio of norisoprenoid to nicotine is about 1:10 to 1:1.[000177] In some examples, the composition may comprise at least one aromatic alcohol which is optionally a C7 to C18 monoalcohol, optionally selected from benzyl alcohol, phenylethanol, phenylmethylcarbinol, 1-phenylpropane-1,2-diol, 1-phenyl-2-butanol, and combinations thereof.[000178] In some examples, the composition further comprises one or more carboxylate esters. In some examples, the carboxylate ester is selected from: ethyl acetate; isopropyl formate; methyl methoxyacetate; methyl 2-methylbutyrate; propanoic acid, 2-hydroxy-, ethyl ester; ethyl isovalerate; mono-ethyl succinate; isoamyl isovalerate; 2-methylpentanoyl 2-methylpentanoate; triethyl citrate; 1, 2, 3-propanetriol,1 -acetate; 2-hydroxypropylacetate; 1,1 -ethanediol, diacetate; dibutyl phthalate; acetic acid, methyl ester; bis(2-ethylhexyl) benzene-1,3-dicarbuoxylate;methyl phenylacetate; methyl nicotinate; proline, 2-methyl-5-oxo-, methyl ester; methyl pyruvate; ethyl pyruvate; methyl palmitate; ethyl palmitate; and combinations thereof.[000179] In some examples, the composition further comprises at least one sesquiterpene which optionally may be selected from calamenene, alpha-muurolene, r-cadinene, viridiflorene, longifolene, nootkatone, beta-bisabolol, cedrol, nerolidol, santalol, beta-bisabolene, beta-cedrene, beta-humulene, alpha-cyperone, cyperotundone, 3,7-dimethyl-10-(propan-2-ylidene)cyclodeca-3,7-dienone, solavetivone, alantolactone, neophytadiene, guai-1(5)-en-11-okacetate, and combinations thereof.[000180] In some examples, the composition further comprises one or more furan derivatives which are optionally selected from furfuryl alcohol, furfural, 5-methyl furfural, ethanone, 1-(2-furanyl)-, 2-pentylfuran, 2-(propan-2-ylsulfanylmethyl)furan, 1-(furan-2-yl)pentan-1-one, furfuryl methyl ether, 2-acetylfuran, 2-acetyl-5-methylfuran, linalooloxide, 2-ethenyl-furan, 5-hydroxymethylfurfural, or a combination thereof.Smoke Markers[000181] In some examples the compositions of the present disclosure include compounds which may be absent from a tobacco extract, but present in smoke formed by burning the same tobacco used to form the extract, e.g. in a cigarette. As noted above, these compounds are termed ‘smoke markers’. These compounds may also be considered irritation and / or tobacco flavour markers.[000182] The smoke markers may be one or more compounds selected from: 3-Methyl-1H-pyrazole-4-carbaldehyde, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1-(acetyloxy)-, 2-pyrrolidinone, methylcyclopentenolone, furfural, 1H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1 -(1 H-pyrrol-2-yl)-, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, 1H-pyrrole-2-carboxyaldehyde, 1 -methyl-, ethanone, 1-(2-furanyl)-, dimethylpyrazine, pyrazine, ethyl-, trimethylpyrazine, Ethylguaiacol, ethanone, 1-(3-pyridinyl)-, strawberry furanone, 2-pentadecanone, 6, 10, 14-trimethyl-, n-hexadecanoic acid, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, 1 ,2-cyclopentanedione, 3-methyl-, butyrolactone, 2-furanmethanol, 3-methylpentanoic acid, phenol, 5-ethenyl-2-methoxy-, tetradecanoic acid, and acetic acid.[000183] In some examples, the composition may comprise one or more compounds selected from 3-Methyl-1H-pyrazole-4-carbaldehyde, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1- (acetyl oxy)-, 2-pyrrolidinone, methylcyclopentenolone, and furfural. In some examples, the composition may comprise two or more compounds selected from 3-Methyl-1H-pyrazole-4-carbaldehyde, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1-(acetyloxy)-, 2-pyrrolidinone, methylcyclopentenolone, and furfural. In some examples, the composition may comprise three or more compounds selected from 3-M ethyl- 1 H-pyrazole-4-carbaldehyde, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1 -(acetyloxy)-, 2-pyrrolidinone, methylcyclopentenolone, and furfural. In some examples, the composition may comprise four or more compounds selected from 3-Methyl-1H-pyrazole-4-carbaldehyde, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1 -(acetyloxy)-, 2-pyrrolidinone, methylcyclopentenolone, and furfural. In some examples, the composition may comprise five or more compounds selected from 3-Methyl-1H-pyrazole-4-carbaldehyde, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1 -(acetyloxy)-, 2-pyrrolidinone, methylcyclopentenolone, and furfural. In some examples, the composition may comprise six or more compounds selected from 3-Methyl-1H-pyrazole-4-carbaldehyde, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1- (acetyl oxy)-, 2-pyrrolidinone, methylcyclopentenolone, and furfural. In some examples, the composition may comprise 3-Methyl-1H-pyrazole-4-carbaldehyde, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1 -(acetyloxy)-, 2-pyrrolidinone, methylcyclopentenolone, and furfural.[000184] In some examples, the composition comprises one or more compounds selected from 1H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1-(1 H-pyrrol-2-yl)-, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, 1H-pyrrole-2-carboxyaldehyde, 1 -methyl-, ethanone, 1-(2-furanyl)-, dimethylpyrazine, pyrazine, ethyl-, trimethylpyrazine, Ethylguaiacol, ethanone, 1-(3-pyridinyl)-, strawberry furanone, 2-pentadecanone, 6, 10, 14-trimethyl-, n-hexadecanoic acid, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, 1 ,2-cyclopentanedione, 3-methyl-, butyrolactone, and 2-furanmethanol. In some examples, the composition comprises two or more compounds selected from 1 H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1-(1H-pyrrol-2-yl)-, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, 1H-pyrrole-2-carboxyaldehyde, 1-methyl-, ethanone, 1-(2-furanyl)-, dimethylpyrazine, pyrazine, ethyl-, trimethylpyrazine, Ethylguaiacol, ethanone, 1 -(3-pyridinyl)-, strawberry furanone, 2-pentadecanone, 6, 10, 14-trimethyl-, n-hexadecanoic acid, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, 1,2-cyclopentanedione, 3-methyl-, butyrolactone, and 2-furanmethanol. In some examples, the composition comprises three or more compounds selected from 1 H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1 -(1 H-pyrrol-2-yl)-, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, 1 H-pyrrole-2-carboxyaldehyde, 1-methyl-, ethanone, 1-(2-furanyl)-, dimethylpyrazine, pyrazine, ethyl-, trimethylpyrazine, Ethylguaiacol, ethanone, 1 -(3-pyridinyl)-, strawberry furanone, 2-pentadecanone, 6, 10, 14-trimethyl-, n-hexadecanoic acid, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, 1,2-cyclopentanedione, 3-methyl-, butyrolactone, and 2-furanmethanol. In some examples, thecomposition comprises four or more compounds selected from 1H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1 -(1 H-pyrrol-2-yl)-, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, 1H-pyrrole-2-carboxyaldehyde, 1 -methyl-, ethanone, 1-(2-furanyl)-, dimethylpyrazine, pyrazine, ethyl-, trimethylpyrazine, Ethylguaiacol, ethanone, 1-(3-pyridinyl)-, strawberry furanone, 2-pentadecanone, 6, 10, 14-trimethyl-, n-hexadecanoic acid, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, 1 ,2-cyclopentanedione, 3-methyl-, butyrolactone, and 2-furanmethanol. In some examples, the composition comprises five or more compounds selected from 1H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1 -(1 H-pyrrol-2-yl)-, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, 1 H-pyrrole-2-carboxyaldehyde, 1-methyl-, ethanone, 1-(2-furanyl)-, dimethylpyrazine, pyrazine, ethyl-, trimethylpyrazine, Ethylguaiacol, ethanone, 1 -(3-pyridinyl)-, strawberry furanone, 2-pentadecanone, 6, 10, 14-trimethyl-, n-hexadecanoic acid, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, 1 ,2-cyclopentanedione, 3-methyl-, butyrolactone, and 2-furanmethanol. In some examples, the composition comprises six or more compounds selected from 1 H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1 -(1 H-pyrrol-2-yl)-, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, 1H-pyrrole-2-carboxyaldehyde, 1 -methyl-, ethanone, 1-(2-furanyl)-, dimethylpyrazine, pyrazine, ethyl-, trimethylpyrazine, Ethylguaiacol, ethanone, 1-(3-pyridinyl)-, strawberry furanone, 2-pentadecanone, 6, 10, 14-trimethyl-, n-hexadecanoic acid, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, 1 ,2-cyclopentanedione, 3-methyl-, butyrolactone, and 2-furanmethanol. In some examples, the composition comprises 1H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1 -(1 H-pyrrol-2-yl)-, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, 1H-pyrrole-2-carboxyaldehyde, 1 -methyl-, ethanone, 1-(2-furanyl)-, dimethylpyrazine, pyrazine, ethyl-, trimethylpyrazine, Ethylguaiacol, ethanone, 1-(3-pyridinyl)-, strawberry furanone, 2-pentadecanone, 6, 10, 14-trimethyl-, n-hexadecanoic acid, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, 1 ,2-cyclopentanedione, 3-methyl-, butyrolactone, and 2-furanmethanol.[000185] In some examples, the composition comprises one or more compounds selected from: 3-Methyl-1H-pyrazole-4-carbaldehyde, 3-methylpentanoic acid, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1 -(acetyloxy)-, 2-pyrrolidinone, methylcyclopentenolone, furfural, 3-methylpentanoic acid, and phenol, 5-ethenyl-2-methoxy-. In some examples, the composition comprises two or more compounds selected from: 3-Methyl-1H-pyrazole-4-carbaldehyde, 3-methylpentanoic acid, benzene, 1-isocyano-3-methyl-4-vinylphenol, 2-propanone, 1 -(acetyloxy)-, 2-pyrrolidinone, methylcyclopentenolone, furfural, 3-methylpentanoic acid, and phenol, 5-ethenyl-2-methoxy-. In some examples, the composition comprises three or more compounds selected from: 3-Methyl-1H-pyrazole-4-carbaldehyde, 3-methylpentanoic acid, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1-(acetyloxy)-, 2-pyrrolidinone, methylcyclopentenolone, furfural, 3-methylpentanoic acid, and phenol, 5-ethenyl-2-methoxy-. In some examples, the composition comprises four or more compounds selected from: 3-Methyl-1H-pyrazole-4-carbaldehyde, 3-methylpentanoic acid, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1 -(acetyloxy)-, 2-pyrrolidinone, methylcyclopentenolone, furfural, 3-methylpentanoic acid, and phenol, 5-ethenyl-2-methoxy-. In some examples, the composition comprises five or more compounds selected from: 3-Methyl-1H-pyrazole-4-carbaldehyde, 3-methylpentanoic acid, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1 -(acetyloxy)-, 2-pyrrolidinone, methylcyclopentenolone, furfural, 3-methylpentanoic acid, and phenol, 5-ethenyl-2-methoxy-. In some examples, the composition comprises six or more compounds selected from: 3-Methyl-1H-pyrazole-4-carbaldehyde, 3-methylpentanoic acid, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1-(acetyloxy)-, 2-pyrrolidinone, methylcyclopentenolone, furfural, 3-methylpentanoic acid, and phenol, 5-ethenyl-2-methoxy-. In some examples, the composition comprises 3-M ethyl- 1H-pyrazole-4-carbaldehyde, 3-methylpentanoic acid, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1 -(acetyloxy)-, 2-pyrrolidinone, methylcyclopentenolone, furfural, 3-methylpentanoic acid, and phenol, 5-ethenyl-2-methoxy-.[000186] In some examples, the composition comprises one or more compounds selected from: 1H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1-(1 H-pyrrol-2-yl)-, dimethylpyrazine, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, ethanone, 1-(2-furanyl)-, pyrazine, ethyl-, trimethylpyrazine, strawberry furanone, 2-pentadecanone, 6,10,14-trimethyl-, tetradecanoic acid, n-hexadecanoic acid, 2-propanone, 1 -(acetyloxy)-, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, acetic acid, 1,2-cyclopentanedione, 3-methyl-, butyrolactone, 2-furanmethanol, methylcyclopentenolone, and furfural. In some examples, the composition comprises two or more compounds selected from: 1 H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1 -(1 H-pyrrol-2-yl)-, dimethylpyrazine, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, ethanone, 1-(2-furanyl)-, pyrazine, ethyl-, trimethylpyrazine, strawberry furanone, 2-pentadecanone, 6, 10, 14-trimethyl-, tetradecanoic acid, n-hexadecanoic acid, 2-propanone, 1- (acetyl oxy)-, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, acetic acid, 1,2-cyclopentanedione, 3-methyl-, butyrolactone, 2-furanmethanol, methylcyclopentenolone, and furfural. In some examples, the composition comprises three or more compounds selected from: 1H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1-(1 H-pyrrol-2-yl)-, dimethylpyrazine, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, ethanone, 1-(2-furanyl)-, pyrazine, ethyl-, tri methyl pyrazine, strawberry furanone, 2-pentadecanone, 6, 10, 14-trimethyl-, tetradecanoic acid, n-hexadecanoic acid, 2-propanone, 1-(acetyloxy)-, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, acetic acid, 1,2-cyclopentanedione, 3-methyl-, butyrolactone, 2-furanmethanol, methylcyclopentenolone, andfurfural. In some examples, the composition comprises four or more compounds selected from: 1H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1 -(1 H-pyrrol-2-yl)-, dimethylpyrazine, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, ethanone, 1-(2-furanyl)-, pyrazine, ethyl-, trimethylpyrazine, strawberry furanone, 2-pentadecanone, 6, 10,14-tri methyl-, tetradecanoic acid, n-hexadecanoic acid, 2-propanone, 1 -(acetyloxy)-, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, acetic acid, 1,2-cyclopentanedione, 3-methyl-, butyrolactone, 2-furanmethanol, methylcyclopentenolone, and furfural. In some examples, the composition comprises five or more compounds selected from: 1H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1-(1 H-pyrrol-2-yl)-, dimethylpyrazine, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, ethanone, 1-(2-furanyl)-, pyrazine, ethyl-, trimethylpyrazine, strawberry furanone, 2-pentadecanone, 6, 10, 14-trimethyl-, tetradecanoic acid, n-hexadecanoic acid, 2-propanone, 1- (acetyl oxy)-, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, acetic acid, 1,2-cyclopentanedione, 3-methyl-, butyrolactone, 2-furanmethanol, methylcyclopentenolone, and furfural. In some examples, the composition comprises six or more compounds selected from: 1H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1-(1 H-pyrrol-2-yl)-, dimethylpyrazine, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, ethanone, 1-(2-furanyl)-, pyrazine, ethyl-, tri methyl pyrazine, strawberry furanone, 2-pentadecanone, 6, 10, 14-trimethyl-, tetradecanoic acid, n-hexadecanoic acid, 2-propanone, 1-(acetyloxy)-, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, acetic acid, 1,2-cyclopentanedione, 3-methyl-, butyrolactone, 2-furanmethanol, methylcyclopentenolone, and furfural. In some examples, the composition comprises 1H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1-(1 H-pyrrol-2-yl)-, dimethylpyrazine, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, ethanone, 1-(2-furanyl)-, pyrazine, ethyl-, trimethylpyrazine, strawberry furanone, 2-pentadecanone, 6, 10, 14-trimethyl-, tetradecanoic acid, n-hexadecanoic acid, 2-propanone, 1- (acetyl oxy)-, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, acetic acid, 1,2-cyclopentanedione, 3-methyl-, butyrolactone, 2-furanmethanol, methylcyclopentenolone, and furfural.[000187] When present, each of the smoke markers may be included in an amount of about 0.1 to about 20 ug / mL. The total amount of smoke markers in the composition may from about 100 to about 500 ug / mL. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly relative to the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w.Further Embodiments[000188] When present, each of the smoke markers may be included in an amount of about 0.1 to about 20 ug / mL.[000189] When present, each lactone may be included in an amount of about 1 pg / g to about 300 pg / g.[000190] When present, each ketone may be included in an amount of about 0.1 pg / g to about 300 pg / g, such as from about 20 pg / g to about 850 pg / g.[000191] When present, each aromatic aldehyde may be included in an amount of about 0.1 pg / g to about 10 pg / g, such as from about 0.5 pg / g to about 10 pg / g.[000192] When present, each aliphatic aldehyde may be present in the composition in an amount of from about 0.1 pg / g to about 100 pg / g.[000193] When present, each C5 to C24 fatty acid may be present in the composition in an amount of from about 0.1 pg / g to about 300 pg / g.[000194] When present, each substituted phenol may be present in the composition in an amount of from about 0.1 pg / g to about 600 pg / g.[000195] When present, each aromatic alcohol may be present in the composition in an amount of from about 0.5 pg / g to about 100 pg / g.Non-Combustible Aerosol Provision System[000196] A non-combustible aerosol provision system is a system that releases compounds from an aerosol-generating material without combusting the aerosol-generating material, such as electronic cigarettes, tobacco heating products, and hybrid systems to generate aerosol using a combination of aerosol-generating materials.[000197] According to the present disclosure, a “non-combustible” aerosol provision system is one where a constituent aerosol-generating material of the aerosol provision system (or component thereof) is not combusted or burned in order to facilitate delivery of at least one substance to a user. The aerosol provision system may also be referenced herein as an aerosol delivery system. In some examples, the delivery system is a non-combustible aerosol provision system, such as a powered non-combustible aerosol provision system. In some examples, the non-combustible aerosol provision system is an electronic cigarette, also known as a vapingdevice or electronic nicotine delivery system (END), although it is noted that the presence of nicotine in the aerosol-generating material is not a requirement.[000198] In some examples, the non-combustible aerosol provision system is an aerosolgenerating material heating system, also known as a heat-not-burn system. An example of such a system is a tobacco heating system.[000199] In some examples, the non-combustible aerosol provision system is a hybrid system to generate aerosol using a combination of aerosol-generating materials, one or a plurality of which may be heated. Each of the aerosol-generating materials may be, for example, in the form of a solid, liquid or gel and may or may not contain nicotine. In some examples, the hybrid system comprises a liquid or gel aerosol-generating material and a solid aerosol-generating material. The solid aerosol-generating material may comprise, for example, tobacco or a nontobacco product. Typically, the non-combustible aerosol provision system may comprise a non-combustible aerosol provision device and an article for use with or as the non-combustible aerosol provision device, which is also referred to as a consumable for use with the non-combustible aerosol provision device. In some examples, the disclosure relates to consumables comprising aerosol-generating material and configured to be used with non-combustible aerosol provision devices. These consumables are sometimes referred to as articles throughout the disclosure.[000200] In some examples, the non-combustible aerosol provision system, such as a non-combustible aerosol provision device thereof, may comprise a power source and a controller. The power source may, for example, be an electric power source or an exothermic power source. In some examples, the exothermic power source comprises a carbon substrate which may be energised so as to distribute power in the form of heat to an aerosol-generating material or to a heat transfer material in proximity to the exothermic power source.[000201] In some examples, the non-combustible aerosol provision system may comprise an area for receiving the consumable, an aerosol generator, an aerosol generation area, a housing, a mouthpiece, a filter and / or an aerosol-modifying agent. In some examples, the consumable for use with the non-combustible aerosol provision device may comprise aerosol-generating material, an aerosol-generating material storage area, an aerosol-generating material transfer component, an aerosol generator, an aerosol generation area, a housing, a wrapper, a filter, a mouthpiece, and / or an aerosol-modifying agent.[000202] The terms aerosolisable formulation, aerosolisable material, and aerosol-generating material, are used interchangeably herein. Hence, there is provided an aerosolisableformulation comprising the composition as defined herein, an aerosol-former material and optionally nicotine. In some examples the formulation comprises the composition as defined herein, an aerosol-former material and nicotine. In some examples the formulation comprises the composition in an amount of at least about 1% by weight, such as at least about 5 wt% by weight, preferably at least about 10 wt% by weight. The composition may be present in the formulation in an amount of no greater than about 25% by weight, such as no greater than about 20% by weight, preferably no greater than about 15 wt% by weight. In some examples the composition may be present in the formulation in an amount of from about 1% by weight to about 25% by weight, such as from about 5 wt% by weight to about 20% by weight, preferably from about 10% by weight to about 15% by weight.[000203] The aerosolisable formulation may take various forms, provided that the formulation is capable of generating aerosol, for example when heated, irradiated or energized in any other way, including a semi-solid (such as a gel), a liquid or a solid, which may or may not contain an active substance and / or flavourants as defined herein. The aerosol-generating material may comprise one or more active substances and / or flavours, one or more aerosol-former materials, and optionally one or more other functional material.[000204] In some examples, the aerosolisable formulation is a liquid. In some examples the formulation is a liquid and comprises about 1% to about 25% by weight of the composition, about 50 to about 99% by weight of the aerosol-former material, and optionally nicotine, such as about 5 wt% by weight to about 20% by weight of the composition, about 60% to about 98% by weight of the aerosol-former material, and optionally nicotine, preferably about 10% by weight to about 15% by weight of the composition, about 70% to about 95% by weight of the aerosolformer material, and optionally nicotine.[000205] Nicotine may be provided in any suitable amount depending on the desired dosage when the formulation is aerosolised and inhaled by the user. Nicotine may be included in the composition even if it is already present in the composition. In some examples nicotine is present in an amount of no greater than about 6 wt% based on the total weight of the formulation. In some examples nicotine is present in an amount of from about 0.1 to about 6 wt% based on the total weight of the formulation, such as from about 0.5 to about 6 wt% based on the total weight of the formulation, preferably about 0.5 to about 5 wt% based on the total weight of the formulation.[000206] In some examples the aerosolisable formulation is a liquid and may comprise about 1% to about 25% by weight of the composition, where the composition is defined according tothe examples above, about 50 to about 99 wt% of the aerosol-former material, and about 0.1 to about 6 wt% of nicotine.[000207] In some examples the formulation may contain one or more acids in addition to nicotine (as the active agent). In some examples, the one or more acids may be one or more organic acids. In some examples, the one or more acids may be one or more organic acids selected from the group consisting of benzoic acid, levulinic acid, malic acid, maleic acid, fumaric acid, citric acid, lactic acid, acetic acid, succinic acid, and mixtures thereof. When included in the formulation in combination with nicotine, the one or more acids may provide a formulation in which the nicotine is at least partially in protonated (such as monoprotonated and / or diprotonated) form.[000208] In some examples, the aerosolisable formulation / aerosol-generating material may be an extruded material or in the form of strands or strips. In some examples there is provided an aerosol generating material / system comprising the composition as defined herein, an aerosol former material, one or more binders, and optionally a botanical material. Optionally a filler may also be present. Optionally, a solvent, such as water, is also present and one or more other components of the aerosol-generating material may or may not be soluble in the solvent.[000209] The aerosol-generating material may comprise or be in the form of an aerosolgenerating film. The aerosol-generating film may comprise a binder, such as a gelling agent, and an aerosol former. Optionally, a substance to be delivered and / or filler may also be present. The aerosol-generating film may have a thickness of about 0.015 mm to about 1 mm. For example, the thickness may be in the range of about 0.05 mm, 0.1 mm or 0.15 mm to about 0.5 mm or 0.3 mm. The aerosol-generating film may be continuous. For example, the film may comprise or be a continuous sheet of material. The sheet may be in the form of a wrapper, it may be gathered to form a gathered sheet or it may be shredded to form a shredded sheet. The shredded sheet may comprise one or more strands or strips of aerosol-generating material.[000210] The aerosol-generating film may be discontinuous. For example, the aerosolgenerating film may comprise one or more discrete portions or regions of aerosol-generating material, such as dots, stripes or lines, which may be supported on a support. In such examples, the support may be planar or non-planar.[000211] The aerosol-generating film may be formed by combining a binder, such as a gelling agent, with a solvent, such as water, an aerosol-former and one or more other components, such as one or more substances to be delivered, to form a slurry and then heating the slurry tovolatilise at least some of the solvent to form the aerosol-generating film. The slurry may be heated to remove at least about 60 wt%, 70 wt%, 80 wt%, 85 wt% or 90 wt% of the solvent.[000212] The aerosol-generating material may comprise or be an “amorphous solid”. In some examples, the aerosol-generating materiel comprises an aerosol-generating film that is an amorphous solid. The amorphous solid may be a “monolithic solid”. The amorphous solid may be substantially non-fibrous. In some examples, the amorphous solid may be a dried gel. The amorphous solid is a solid material that may retain some fluid, such as liquid, within it. In some examples, the amorphous solid may, for example, comprise from about 50wt%, 60wt% or 70wt% of amorphous solid, to about 90wt%, 95wt% or 100wt% of amorphous solid.[000213] In some examples, the binder consists of one or more gelling agent(s). Suitably, the aerosolisable formulation or aerosol generating system comprises from about 2 wt% to about 80 wt% binder(s), for example from about 5 wt%, 7 wt%, 10 wt%, 15 wt%, 17 wt%, 20 wt%, or 25 wt% to about 70 wt%, 60 wt%, 50 wt%, 45 wt%, 40 wt%, 35 wt% or 30 wt% of one or more binders (all calculated on a dry weight basis). For example, the aerosolisable formulation or aerosol generating system may comprise about 5-70 wt%, 7-60 wt%, 10-50 wt%, 15-45 wt%, 17-40 wt%, 20-35 wt% or 25-30 wt% of the binder(s).[000214] In some examples, the one or more binders comprises one or more gelling agent(s). In some examples, the one or more binders consist of one or more gelling agent(s). In some examples, the gelling agent comprises a hydrocolloid.[000215] In some examples, the one or more binders comprises (or is) one or more compounds selected from polysaccharide gelling agents, such as alginate, pectin, starch or a derivative thereof, cellulose or a derivative thereof, pullulan, carrageenan, agar and agarose; gelatin; gums, such as xanthan gum, guar gum and acacia gum; silica or silicone compounds, such as PDMS and sodium silicate; clays, such as kaolin; and polyvinyl alcohol.[000216] In some examples the one or more binders comprises (or is) one or more polysaccharide gelling agents. In some examples, the polysaccharide gelling agent is selected from alginate, pectin, starch or a derivative thereof, or cellulose or a derivative thereof. In some examples the polysaccharide gelling agent is selected from alginate and a cellulose derivative.[000217] In some examples, the one or more binders is a polysaccharide gelling agent, optionally wherein the polysaccharide gelling agent is selected from alginate and a cellulose derivative. In some examples, the polysaccharide gelling agent is alginate. In some examples, the alginate is sodium alginate.[000218] In some examples, the polysaccharide gelling agent is a cellulose derivative. Without wishing to be bound by theory, it is believed that such gelling agents do not react with calcium ions to form crosslinks. In some examples the binder is not crosslinked. The absence of crosslinks in the gelling agent may facilitate quicker delivery of the composition (and any optional additional active substances and / or flavours) from the aerosolisable formulation or aerosol generating system. Examples of cellulosic binders (also referred to herein as cellulosic gelling agents or cellulose derivatives) include, but are not limited to, hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethylcellulose (CMC), hydroxypropyl methylcellulose (HPMC), methyl cellulose, ethyl cellulose, cellulose acetate (CA), cellulose acetate butyrate (CAB), and cellulose acetate propionate (CAP). In some examples the cellulose or derivative thereof is selected from hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethylcellulose (CMC), hydroxypropyl methylcellulose (HPMC), methyl cellulose, ethyl cellulose, cellulose acetate (CA), cellulose acetate butyrate (CAB), and cellulose acetate propionate (CAP). In some examples, the cellulose derivative is CMC. For example, in some examples, the binder comprises (or is) one or more of alginate, pectin, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethylcellulose, pullulan, xanthan gum, guar gum, carrageenan, agarose, acacia gum, fumed silica, PDMS, sodium silicate, kaolin and polyvinyl alcohol.[000219] In some examples, the binder comprises (or is) one or more of hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethylcellulose, guar gum, acacia gum, alginate and / or pectin. In some cases, the binder comprises (or is) alginate and / or pectin, and may be combined with a setting agent (such as a calcium source) during formation of the aerosolisable formulation or aerosol generating system. In some cases, the binder may comprise a calcium-crosslinked alginate and / or a calcium-crosslinked pectin. In some examples, the binder comprises (or is) alginate, optionally wherein the alginate is present in the aerosolisable formulation in an amount of from about 5-70 wt%, 7-60 wt%, 10-50 wt%, or 15-45 wt%, of the aerosolisable formulation or aerosol generating system (calculated on a dry weight basis). In some examples, alginate is the only binder present in the aerosolisable formulation / aerosol generating system. In other examples, the binder comprises alginate and at least one further binder, such as pectin. In particular examples, the binder is carboxymethylcellulose, optionally wherein the carboxymethylcellulose (CMC) is present in an amount of about 2-80 wt%, for example about 5-70 wt%, 10-60 wt%, 15-50 wt%, 17-45 wt%, 20-40 wt% or about 30 wt%. In some examples, CMC is the only binder present in the aerosolisable formulation / aerosol generating system.[000220] The aerosolisable formulation or aerosol generating material may further comprise a filler. Use of a filler may help to reduce tackiness of the aerosolisable formulation / aerosolgenerating material, for example if high levels of aerosol-former material are present. Suitably, the aerosolisable formulation / aerosol generating material comprises from about 2 wt% to about 60 wt% binder and any optional filler. In some examples, filler is present in an amount of less than about 50 wt% of a filler, such as from about 1 wt% to 50 wt%, or 5 wt% to 40 wt%, or 5 wt% to 30 wt%, or 10 wt% to 20 wt%. In other examples, filler is present in an amount of less than 20 wt%, suitably less than 10 wt% or less than 5 wt%. In some cases, the aerosolisable formulation comprises less than 1 wt% of a filler, and in some cases, comprises no filler. The filler, if present, may comprise one or more inorganic filler materials, such as calcium carbonate, perlite, vermiculite, diatomaceous earth, colloidal silica, magnesium oxide, magnesium sulphate, magnesium carbonate, and suitable inorganic sorbents, such as molecular sieves. The filler may comprise one or more organic filler materials such as wood pulp; tobacco pulp; hemp fibre; starch and starch derivatives, such as maltodextrin; chitosan; and cellulose and cellulose derivatives, such as ground cellulose, microcrystalline cellulose and nanocrystalline cellulose. In particular cases, the aerosolisable formulation comprises no calcium carbonate such as chalk.[000221] In particular examples which include filler, the filler is fibrous. For example, the filler may be a fibrous organic filler material such as wood pulp, tobacco pulp, hemp fibre, cellulose or cellulose derivatives. In some examples, the fibrous organic filler material may be wood pulp, hemp fibre, cellulose or cellulose derivatives. In some examples, the fibrous filler is wood pulp. Without wishing to be bound by theory, it is believed that including fibrous filler in an aerosolisable formulation may increase the tensile strength of the material. This may be particularly advantageous in examples wherein the aerosolisable formulation or aerosol generating material is provided as a sheet, such as when a sheet circumscribes a rod of aerosolisable or aerosol generating material.[000222] The aerosol-former material may comprise one or more constituents capable of forming an aerosol. In some examples, the aerosol-former material may comprise one or more of glycerol, propylene glycol, diethylene glycol, triethylene glycol, tetraethylene glycol, 1,3-butylene glycol, erythritol, meso-Erythritol, ethyl vanillate, ethyl laurate, a diethyl suberate, triethyl citrate, triacetin, a diacetin mixture, benzyl benzoate, benzyl phenyl acetate, tributyrin, lauryl acetate, lauric acid, myristic acid, and propylene carbonate. In heated products, the aerosol-former material can be present in an amount of greater than 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14% or 15% by weight of the aerosol-generating material.[000223] The consumable may comprise one or more further constituents. In particular, one or more further constituents may be selected from one or more active agents, and / or one or more functional constituents. In some examples, it may be desirable for the composition to compriseonly some of the chemical markers disclosed herein, and this composition combined or used with a known active or flavourant, such as menthol or CBD, in a consumable to create a cigarette-like experience with an added sensation or effect.[000224] The active agent as used herein may be a physiologically active material, which is a material intended to achieve or enhance a physiological response. The active agent may, for example, be selected from nutraceuticals, nootropics, psychoactives. The active substance may be naturally occurring or synthetically obtained. The active agent may comprise for example nicotine, caffeine, taurine, theine, vitamins such as B6 or B12 or C, melatonin, cannabinoids, or constituents, derivatives, or combinations thereof. The active substance may comprise one or more constituents, derivatives or extracts of tobacco, cannabis or another botanical. In some examples, the active substance is a legally permissible recreational drug. In some examples, the active agent comprises nicotine. In some examples, the active agent comprises caffeine, melatonin, or vitamin B12.[000225] In some examples, the active agent may comprise one or more constituents, derivatives or extracts of cannabis, such as one or more cannabinoids or terpenes. Cannabinoids are a class of natural or synthetic chemical compounds that act on cannabinoid receptors (i.e., CB1 and CB2) in cells that repress neurotransmitter release in the brain. Cannabinoids are cyclic molecules exhibiting particular properties such as the ability to cross the blood-brain barrier with ease. Cannabinoids may be naturally occurring (phytocannabinoids) from plants such as cannabis, (endocannabinoids) from animals, or artificially manufactured (synthetic cannabinoids). Cannabis species express at least 85 different phytocannabinoids, and these may be divided into subclasses, including cannabigerols, cannabichromenes, cannabidiols, tetrahydrocannabinols, cannabinols and cannabinodiols, and other cannabinoids.[000226] In some examples, the at least one cannabinoid may be selected from cannabigerol (CBG), cannabigerolic acid (CBGA), cannabichromene (CBC), cannabichromenic acid (CBCA), cannabidiol (CBD), cannabidolic acid (CBDA), tetrahydrocannabinol (THC), including its isomers A6a,10a-tetrahydrocannabinol (A6a,10a-THC), A6a(7)-tetrahydrocannabinol (A6a(7)-THC), A8-tetrahydrocannabinol (A8-THC), A9-tetrahydrocannabinol (A9-THC), A10-tetrahydrocannabinol (A10-THC), A9, 11 -tetrahydrocannabinol (A9,11-THC), tetrahydrocannabinolic acid (THCA), cannabinol (CBN), cannabinolic acid (CBNA), and cannabinodiol (CBDL), cannabicyclol (CBL), cannabivarin (CBV), tetrahydrocannabivarin (THCV), cannabidivarin (CBDV), cannabichromevarin (CBCV), cannabigerovarin (CBGV), cannabigerol monomethyl ether (CBGM) and combinations thereof. According to one embodiment, the at least one cannabinoid may be selected from cannabigerol (CBG),cannabichromene (CBC), cannabidiol (CBD), tetrahydrocannabinol (THC), cannabinol (CBN) and combinations thereof.[000227] Naturally derived cannabinoids are generally present in their carboxylated form. In this regard, cannabidiol (CBD) and cannabidolic acid (CBDA) are the respective decarboxylated and carboxylated forms.[000228] The cannabinoid referred to herein may be present in either the carboxylated or decarboxylated form. Exemplary carboxylated cannabinoid in this regard include cannabigerolic acid (CBGA), cannabichromenic acid (CBCA), cannabinolic acid (CBNA), tetrahydrocannabinolic acid (THCA), cannabidolic acid (CBDA) and combinations thereof.[000229] As noted herein, the active substance may comprise or be derived from one or more botanicals or constituents, derivatives or extracts thereof. As used herein, the term “botanical” includes any material derived from plants including, but not limited to, extracts, leaves, bark, fibres, stems, roots, seeds, flowers, fruits, pollen, husk, shells or the like. Alternatively, the material may comprise an active compound naturally existing in a botanical, obtained synthetically. The material may be in the form of liquid, gas, solid, powder, dust, crushed particles, an extrudate, granules, pellets, shreds, strips, sheets, or the like. Example botanicals are tobacco, eucalyptus, star anise, hemp, cocoa, cannabis, fennel, lemongrass, peppermint, spearmint, rooibos (Aspalathus linearis), chamomile, flax, ginger, ginkgo biloba, hazel, hibiscus, laurel, licorice (liquorice), matcha, mate, orange skin, papaya, rose, sage, tea such as green tea or black tea, thyme, clove, cinnamon, coffee, aniseed (anise), basil, bay leaves, cardamom, coriander, cumin, nutmeg, oregano, paprika, rosemary, saffron, lavender, lemon peel, mint, juniper, elderflower, vanilla, Wintergreen, beefsteak plant, curcuma, turmeric, sandalwood, cilantro, bergamot, orange blossom, myrtle, cassis, valerian, pimento, mace, damien, marjoram, olive, lemon balm, lemon basil, chive, carvi, verbena, tarragon, geranium, mulberry, ginseng, theanine, theacrine, maca, ashwagandha, damiana, guarana, chlorophyll, baobab or any combination thereof. The mint may be chosen from the following mint varieties: Mentha Arventis, Mentha c.v..Mentha niliaca, Mentha piperita, Mentha piperita citrata c.v., Mentha piperita c.v, Mentha spicata crispa, Mentha cardifolia, Memtha longifolia, Mentha suaveolens variegata, Mentha pulegium, Mentha spicata c.v. and Mentha suaveolens.[000230] In some examples, the active agent comprises or is derived from one or more botanicals or constituents, derivatives or extracts thereof and the botanical is tobacco. In some examples, the active agent comprises or is derived from one or more botanicals or constituents, derivatives or extracts thereof and the botanical is selected from eucalyptus, star anise, cocoa and hemp. In some examples, the active agent comprises or is derived from one or morebotanicals or constituents, derivatives or extracts thereof and the botanical is selected from rooibos and fennel. In some examples, the consumable may include a botanical material in addition to any plant material, e.g. tobacco extract, present in the composition. In some examples, this may be advantageous to include other flavourants and / or aroma compounds and / or active agents in the second plant material.[000231] When nicotine is present in the formulation, it may be present in protonated and / or un-protonated form. In some examples, the formulation comprises nicotine in unprotonated form and nicotine in monoprotonated form. It may also be that small amounts of diprotonated nicotine are present. In one aspect the formulation comprises nicotine in unprotonated form, nicotine in monoprotonated form and nicotine in diprotonated form. As will be understood by one skilled in the art, the protonated form of nicotine may be prepared by reacting unprotonated nicotine with an acid. The acid(s) are one or more suitable acids, such as organic acids. In some examples, the acid is a carboxylic acid. The carboxylic acid may be any suitable carboxylic acid. In some examples, the acid is a mono-carboxylic acid. In some examples, the acid is selected from the group consisting of acetic acid, benzoic acid, levulinic acid, lactic acid, formic acid, citric acid, pyruvic acid, succinic acid, tartaric acid, oleic acid, sorbic acid, propionic acid, phenylacetic acid, and mixtures thereof. In some examples, the acid is benzoic acid and / or levulinic acid. In some examples, the acid is benzoic acid. In alternative examples, the aerosolisable formulation may be free of inorganic acids and their corresponding salts. For example, the aerosolisable formulation may be free of phosphoric acids.[000232] Where present, the amount of organic acid present may vary. The formulation may comprise from about 0.01% to about 10% by weight of organic acid, present as one or more organic acids, based on the total weight of the formulation. In some examples, the formulation comprises at least about 0.01%, at least about 0.1 %, about 0.2%, about 0.3%, about 0.4%, about 0.5%, about 0.6%, about 0.7%, about 0.8%, about 0.9%, about 1 %, about 2%, about 3%, about 4%, about 5%, about 6%, about 7%, about 8%, about 9%, or at least about 10% organic acid by weight, based on the total weight of the formulation. In some preferred examples, the formulation comprises from about 0.01% to about 5% by weight of organic acid. For example, the formulation comprises an organic acid in an amount of from about 0.1% to about 2.5% by weight of the formulation. In the case where a salt of an organic acid is added (e.g., citric acid anhydrate), the percent by weight is calculated based on the weight of the free acid, not including any counter-ion which may be present.[000233] In some examples, the further constituent comprises a flavour. As used herein, the terms "flavour" and "flavourant" refer to materials which, where local regulations permit, may be used to create a desired taste, aroma, or other somatosensorial sensation in a product for adultconsumers. They may include naturally occurring flavour materials, botanicals, extracts of botanicals, synthetically obtained materials, or combinations thereof (e.g., tobacco, cannabis, licorice (liquorice), hydrangea, eugenol, Japanese white bark magnolia leaf, chamomile, fenugreek, clove, maple, matcha, menthol, Japanese mint, aniseed (anise), cinnamon, turmeric, Indian spices, Asian spices, herb, Wintergreen, cherry, berry, red berry, cranberry, peach, apple, orange, mango, clementine, lemon, lime, tropical fruit, papaya, rhubarb, grape, durian, dragon fruit, cucumber, blueberry, mulberry, citrus fruits, Drambuie, bourbon, scotch, whiskey, gin, tequila, rum, spearmint, peppermint, lavender, aloe vera, cardamom, celery, cascarilla, nutmeg, sandalwood, bergamot, geranium, khat, naswar, betel, shisha, pine, honey essence, rose oil, vanilla, lemon oil, orange oil, orange blossom, cherry blossom, cassia, caraway, cognac, jasmine, ylang-ylang, sage, fennel, wasabi, piment, ginger, coriander, coffee, hemp, a mint oil from any species of the genus Mentha, eucalyptus, star anise, cocoa, lemongrass, rooibos (Aspalathus linearis), flax, ginkgo biloba, hazel, hibiscus, laurel, mate, orange skin, rose, tea such as green tea or black tea, thyme, juniper, elderflower, basil, bay leaves, cumin, oregano, paprika, rosemary, saffron, lemon peel, mint, beefsteak plant, curcuma, cilantro, myrtle, cassis, valerian, pimento, mace, damien, marjoram, olive, lemon balm, lemon basil, chive, carvi, verbena, tarragon, limonene, thymol, camphene), flavour enhancers, bitterness receptor site blockers, sensorial receptor site activators or stimulators, sugars and / or sugar substitutes (e.g., sucralose, acesulfame potassium, aspartame, saccharine, cyclamates, lactose, sucrose, glucose, fructose, sorbitol, or mannitol), and other additives such as charcoal, chlorophyll, minerals, botanicals, or breath freshening agents. They may be imitation, synthetic or natural ingredients or blends thereof. They may be in any suitable form, for example, liquid such as an oil, solid such as a powder, or gas.[000234] The flavour may be added to the consumable as part of a so-called “flavour block”, where one or more flavours are blended together and then added to the substrate material.[000235] In some examples, the flavour comprises menthol, spearmint and / or peppermint. In some examples, the flavour comprises flavour components of cucumber, blueberry, citrus fruits and / or redberry. In some examples, the flavour comprises eugenol. In some examples, the flavour comprises flavour components extracted from tobacco. In some examples, the flavour comprises flavour components extracted from cannabis.[000236] In some examples, the flavour may comprise a sensate, which is intended to achieve a somatosensorial sensation which are usually chemically induced and perceived by the stimulation of the fifth cranial nerve (trigeminal nerve), in addition to or in place of aroma or taste nerves, and these may include agents providing heating, cooling, tingling, numbing effect. Asuitable heat effect agent may be, but is not limited to, vanillyl ethyl ether and a suitable cooling agent may be, but not limited to eucalyptol (if not already present in the composition), WS-3.[000237] Where present, a flavouring agent may be included in the formulation in an amount up to about 10% by weight, such as up to about 5% by weight, such as up to about 1 % by weight of the formulation. In some examples, a flavouring agent is present in an amount of from about 0.01% to about 5% by weight, preferably in an amount of from about 0.1% to about 2.5% by weight of the formulation, and more preferably in an amount of from about 0.25% to about 1% by weight of the formulation.[000238] The one or more other functional constituents may comprise one or more of colouring agents, pH regulators, preservatives, stabilizers, and / or antioxidants. A colouring agent may be employed in amounts sufficient to provide the desired physical attributes to the product. The colouring agent may, for example, alter the visual appearance of the formulation and further, may colour-match the formulation to other components of the aerosolisable formulation or other components of a consumable comprising the formulation. In some examples, the colouring agent may be included so as to confer the aerosolisable formulation with a brown appearance.[000239] When the consumable comprises aerosol-generating material, the consumable may further comprise one or more other components, such as an aerosol-generating section, an aerosol-generating material storage area, an aerosol-generating material transfer component, an aerosol generation area, a housing, a wrapper, a mouthpiece, a filter and / or an aerosolmodifying agent.[000240] A consumable may also comprise an aerosol generator, such as a heater, that emits heat to cause the aerosol-generating material to generate aerosol in use. The heater may, for example, comprise combustible material, a material heatable by electrical conduction, or a susceptor. The aerosol-generating section and / or the aerosol-generating material may comprise a cavity for receiving an aerosol-generator, such as a blade or a pin, of a noncombustible aerosol provision device. A susceptor is a material that is heatable by penetration with a varying magnetic field, such as an alternating magnetic field. The susceptor may be an electrically-conductive material, so that penetration thereof with a varying magnetic field causes induction heating of the material. The material may be a magnetic material, so that penetration thereof with a varying magnetic field causes magnetic hysteresis heating of the heating material. The susceptor may be both electrically-conductive and magnetic, so that the susceptor is heatable by both mechanisms. A device or a consumable may comprise the susceptor. For example, the aerosol-generating section of a consumable may comprise aerosol-generating material and a susceptor.[000241] A consumable may be in the form of a rod and may comprise a downstream mouthend and an upstream end.[000242] Consumables are often named according to their length: "regular" (typically in the range 68-75 mm, e.g. from about 68 mm to 25 about 72 mm), "short" or "mini" (68 mm or less), "king-size" (typically in the range 75-91 mm, e.g. from about 79 mm to about 88 mm), "long" or "super-king" (typically in the range 91-105 mm, e.g. from about 94 mm to about 101 mm) and "ultra-long" (typically in the range from about 110 mm to about 121 mm). Typical heating product consumable circumferences are: "regular" (about 23-25 mm), "wide" (greater than 25 mm), "slim" (about 22-23 mm), "demi-slim" (about 19-22 mm), "super-slim" (about 16-19 mm), and "micro-slim" (less than about 16 mm). Accordingly, for example, a consumable in demi-slim size will have a length of about 75 mm and a circumference of about 21 mm. A consumable in a king-size, super-slim format will have a length of about 83 mm and a circumference of about 17 mm, for example.[000243] Articles may include an aerosol-generating material and a downstream portion downstream of the aerosol-generating material, and each format may be produced with downstream portions of different lengths. The downstream portion length will usually be from about 30 mm to 50 mm. A tipping paper connects the downstream portion to the aerosol generating material and will usually have a greater length than the downstream portion, for example from 3 to 10 mm longer, such that the tipping paper covers the downstream portion and overlaps the aerosol generating material, for instance in the form of a rod, to connect the downstream portion to the rod.[000244] The consumable may comprise aerosol-generating material that is wrapped in a wrapper. The wrapper may, for example, be a paper or a paper-backed foil wrapper. The wrapper can be permeable, partially permeable or impermeable to gas.[000245] An aerosol-modifying agent is a substance, typically located downstream of the aerosol generation area, that is configured to modify the aerosol generated, for example by changing the taste, flavour, acidity or another characteristic of the aerosol. The aerosolmodifying agent may be provided in an aerosol-modifying agent release component, that is operable to selectively release the aerosol-modifying agent. The aerosol-modifying agent may, for example, be an additive or a sorbent. The aerosol-modifying agent may, for example, comprise one or more of a flavourant, a colourant, water, and a carbon adsorbent. The aerosolmodifying agent may, for example, be a solid, a liquid, or a gel. The aerosol-modifying agent may be in powder, thread or granule form. The aerosol-modifying agent may be free from filtration material.[000246] An aerosol generator is an apparatus configured to cause aerosol to be generated from the aerosol-generating material. In some examples, the aerosol generator is a heater configured to subject the aerosol-generating material to heat energy, so as to release one or more volatiles from the aerosol-generating material to form an aerosol. In some examples, the aerosol generator is configured to cause an aerosol to be generated from the aerosol-generating material without heating. For example, the aerosol generator may be configured to subject the aerosol-generating material to one or more of vibration, increased pressure, or electrostatic energy. The aerosol generator may comprise a projection that is configured to subject the aerosol-generating material to heat energy, such as a blade or pin heater. The projection may be configured for insertion into the aerosol-generating section of a consumable. The aerosol generator may be configured to heat the aerosol-generating material to a temperature of up to about 500 °C, about 450 °C, or about 400 ° C or about 350 °C.[000247] Exemplary aerosol generator technologies include: for heater technologies: a resistive heater, an infrared heater, an induction heater, a laser heater, a plasma heater, a microfluidic heater, a convection heater, allotrope of carbon heater, carbon foam heater, a radio-frequency heater, an electro-resistive heater, a halogen heater; for non-heating technology: vibration vaporiser, surface acoustic wave vaporiser, increased pressure vaporiser, electrostatic energy vaporiser, an ultrasonic vaporiser.Process[000248] In another aspect there is provided a process for forming the aerosolised formulation of the present disclosure, the process comprising providing a consumable as defined herein, wherein the consumable comprises aerosol-former material, and aerosolising the consumable. The process may alternatively comprise providing the aerosol generating system as defined herein or the aerosol provision system defined herein and aerosolising the formulation or consumable in the system.[000249] The present invention will now be described with reference to the following nonlimiting examples.ExamplesExample 1[000250] The inventors have identified a range of compounds responsible for the tobacco flavour and / or irritation experience of smoking a traditional cigarette (sometimes called a factory made cigarette or FMC). The compounds were identified by collecting and analysing the smokeproduced from burning cigarettes. Analysis was performed using HTS-HRMS (High Throughput Screening coupled with High Resolution Mass Spectroscopy) and GC-MS data. Specifically, compounds could be identified based on exact monoisotopic mass and isotopic patterns from HTS-HRMS data and from GC-MS data, as compared to reference MS libraries and reference compounds. Human sensory assessment was also used to identify compounds that provided irritation and tobacco flavour.[000251] A machine learning model was created, trained and validated using more than 1,000 samples that were previously assessed by human sensory panels and GC-MS chemosensory analysis, to determine for each compound whether it would enhance or decrease one or more categories or dimensions associated with providing an ‘FMC-like’ experience, namely sense, taste, and flavour. Using partial least squares regression models, compounds were identified that noticeably enhanced tobacco flavour / aroma and / or irritation. The compounds having a VIP (Variable Importance of Projection) higher than 1 for irritation and tobacco flavour were then identified. These compounds were termed irritation and / or tobacco flavour markers. The twenty compounds with the highest VIP for irritation are listed in the table below.[000252] To further refine those compounds acting as key markers for tobacco flavour, the compounds identified in the above assessment were assigned an odour threshold value with reference to compound libraries. An odour threshold value or OTV represents the lowest concentration of a substance that can be detected by the human sense of smell. The twenty compounds that enhanced tobacco flavour with the lowest OTVs, i.e. those easily detected by the human sense of smell, are listed in the table below.Table 1: Chemical Markers for Irritation and Tobacco FlavourTobacco FlavourIrritation Markers CAS No. CAS No.MarkersMyosmine 1125-96-8 Methylbutyric acid* 116-53-0 p-cresol 106-44-5 Piperonal 120-57-0 Pyridine, 4-ethenyl- 100-43-6 Indole 120-72-92-cyclopenten-1- one, 2-hydroxy-3- 80-71-7 Ethyl vanillin 121-32-4 methyl-**1H-indole, 6-methyl- 3420-02-8 Vanillin* 121-33-5 Nicotyrine 487-19-4 Methylacetophenone 122-00-9 Propanoic acid, 2- 600-22-6 Phenylacetaldehyde 122-78-1 oxo, methyl esterPropanoic acid, 2- 79-31-2 Anisaldehyde 123-11-5 methyl- 2-Cyclopenten-1- 2758-18-1 Nonanal 124-19-6 one, 3-methyl-D- Limonene 5989-27-5 Ethylguaiacol 2785-89-96-Ethyl-5,6-dihydro- 19895-35-3 alpha- Linolenic acid 463-40-12H-pyran-2-onePhenol 108-95-2 Eucalyptol 470-82-6 Phenol, 4-ethyl- 123-07-9 Isovaleric acid 503-74-2 Propanoic acid 79-09-4 2,3-Pentanedione 600-14-6 Styrene 100-42-5 Hexanal 66-25-1 Benzene, 1,3- 108-38-3 Methoxyvinylphenol 7786-61-0 dimethyl- 3-Pyridinol 109-00-2 Linalool 78-70-62,3- 5150-42-5 Piperitone 89-81-6 Dimethoxyphenol2-Pentadecanone,502-69-2 Guaiacol 90-05-16, 10, 14- trimethyl- 2-Cyclopenten-1- one, 3-ethyl-2- 21835-01-8 Terpineol 98-55-5hydroxy-***compound also identified as enhancing irritation but with a VIP of less than 1.**compound also identified as enhancing tobacco flavour but with no OTV identified Example 2[000253] Two tobacco extracts were formed from a blend of flue-cured Virginia, air-cured Burley, sun-cured Oriental and fire-cured Dark tobacco. Each of these extracts was then chemically analysed to determine which of the chemical markers present in Example 1 was present. The analysis was performed using GC-MS. Specifically, compounds could be identified based on GC-MS spectra as compared to reference MS libraries and reference compounds. The peaks / compounds representing 95% of total peak area and present in at least 3 replicates were investigated to ensure that the compounds were representatively present. The results are set out below.Table 2: Extract analysis - Irritation MarkersIrritation Markers CAS No.Myosmine 1125-96-8Nicotyrine 487-19-4D- Limonene 5989-27-56-Ethyl-5,6-dihydro- 19895-35-32H-pyran-2-onePhenol 108-95-2Table 3: Extract analysis - Tobacco Flavour MarkersTobacco FlavourCAS No.MarkersIndole 120-72-9alpha-Linolenic acid 463-40-1Methoxyvinylphenol 7786-61-0Guaiacol 90-05-1**The extracts were also analysed for the presence of any compound having a VIP higher than 1 for tobacco flavour, irrespective of their OTV. The results are set out below.Table 4: Extract analysis - Other Tobacco Flavour MarkersTobacco Flavour Markers CAS No.Acetic acid 64-19-72-furanmethanol 98-00-02-furancarboxaldehyde, 5-methyl 620-02-0Benzyl alcohol 100-51-6 Phenethylalcohol 60-12-82(4H)-benzofuranone, 5,6,7,7a- 17092-92-1tetrahydro-4,4,7a-trimethyl-,(R)n-hexadecanoic acid 57-10-3Octadecanoic acid 57-11-4[000254] Separately, cigarettes comprising the tobacco were burnt, and the compounds present in the smoke identified by collecting and analysing the smoke. The smoke was analysed by collecting total particulate matter (TPM) from the cigarettes on Cambridge filter pads and placing the pads into centrifuge tubes for analysis. Next 10 mL of ethyl acetate was added to each pad and each tube was then spiked with 100pL of 1,4-dibromobenzene (99.9%) standard (ISTD) solution. Samples were shaken at 300rpm for approximately 2 hours on a platform shaker. 50 pL aliquots of each sample were then transferred to 2 mL GC autosampler vials and diluted 20x with ISTD solution for analysis. The analysis was performed on an Agilent GC / MS (7890B-5977A) equipped with a Restek RXi-5 MS chromatographic column (30m x 0.25mm x 0.25pm).[000255] The data was processed using Mass Hunter Unknowns Analysis software version 10.2. using chromatogram deconvolution to find compounds whose spectra were then compared against a PCDL and NIST 20 compound library for identification. This analysis was untargeted and only compounds with a match factor of 70 or above were reported.[000256] Semiquant concentration results were obtained from the relative response of ID’d compounds compared to the ISTD 1,4-dibromobenzene (approximate concentration of 500 ng / mL) as follows:Estimated cone. pg / mL = ISTD cone. (pg / mL) * Component Area I ISTD Areapg / stick = Estimated cone. pg / mL * 10.1mL / 3 sticks[000257] Once identified, the compounds in the FMC smoke were compared with the irritation enhancing markers and tobacco flavour enhancing markers from Example 1, and the irritation enhancing markers and tobacco flavour enhancing markers identified in the extracts.[000258] A similar analysis was carried out to identify the irritation enhancing markers and tobacco flavour enhancing markers in an aerosol obtained by heating e-liquids prepared from the two tobacco extracts in a non-combustible aerosol provision system. The e-liquids included the tobacco extracts at a 10% w / w concentration in 60:40 propylene glycol :glycerol along with nicotine at 18 mg / mL. The aerosol was analysed by collecting TPM from the electronic cigarettes on Cambridge filter pads and placing the pads into centrifuge tubes for analysis. Next 10 mL of ethyl acetate was added to each pad and each tube was then spiked with 100pL of 1,4-dibromobenzene (99.9%) standard (ISTD) solution. Samples were shaken at 300rpm for approximately 2 hours on a platform shaker. 50 pL aliquots of each sample were then transferred to 2 mL GC autosampler vials and diluted 20x with ISTD solution for analysis. The analysis was performed on an Agilent GC / MS (7890B-5977A) equipped with a Restek RXi-5 MS chromatographic column (30m x 0.25mm x 0.25pm).[000259] The data was processed using Mass Hunter Unknowns Analysis software version 10.2 using chromatogram deconvolution to find compounds whose spectra were then compared against a PCDL and NIST 20 compound library for identification. This analysis was untargeted and only compounds with a match factor of 70 or above were reported.[000260] Semiquant concentration results were obtained from the relative response of ID’d compounds compared to the ISTD 1,4-dibromobenzene (approximate concentration of 500 ng / mL) as follows:Estimated cone. pg / mL = ISTD cone. (pg / mL) * Component Area I ISTD Areang / puff = Estimated cone. pg / mL * 10.1mL / 100 puffs*1000[000261] The lists of irritation and tobacco flavour enhancing markers present in the aerosol and FMC smoke were compared to each other. All markers present in the aerosol were present in the FMC smoke, except for acetic acid, cotinine, and butanal, 3-methyl- with Extract 1 and cotinine and 1,6,10,14-hexadecatetraen-3-ol,3,7,11,15-tetramethyl-,(E,E)- and butanal, 3-methyl- with Extract 2. These compounds were only present in the aerosolised formulations.[000262] The tobacco flavour enhancing markers and irritation enhancing markers from the aerosols are set out below. Also included are the concentrations in the aerosols compared with the concentrations in the FMC smoke from each extract.Table 5: Irritation and / or Tobacco Flavour Enhancing Markers in AerosolsAerosol from Extract Aerosol from Extract 12 Tobacco Tobacco Irritation IrritationCompound CAS No. Flavour Flavour Enhancing Enhancing MarkerMarker Marker Marker Phenylacetaldehyde;122-78-1 Yes No Yes No BenzeneacetaldehydeNonanal; Nonyl aldehyde;124-19-6 Yes No Yes No Aldehyde C-9;2,3-Pentanedione;Acetylpropionyl; 2,3- 600-14-6 Yes No - - PentadionePhenethyl alcohol; 2- Phenethyl alcohol; Benzyl 60-12-8 Yes No Yes No carbinolGuaiacol; o- Methoxyphenol; o- 90-05-1 - - Yes No Hydroxyanisole; Phenol, 2- methoxy- Acetic acid; Ethanoic acid 64-19-7 Yes No - - Ethanone, 1-(1H-pyrrol-2- 1072-83-9 Yes No Yes No yi)- Toluene 108-88-3 Yes No Yes No Cotinine; 2-Pyrrolidinone, 1- 486-56-6 No Yes No Yes methyl-5-(3-pyridinyl)-, (S)- Myosmine 532-12-7 Yes Yes Yes Yes Tetradecane 629-59-4 Yes No - - Pentanal; Valeraldehyde 110-62-3 Yes No Yes No 3-Methyl-1 H-pyrazole-4- 1000484- - - No Yes carbaldehyde 37-3Ethylbenzene 100-41-4 Yes No Yes No Dodecane 112-40-3 Yes No Yes No 6,8-nonadien-2-one,8- methyl-5-(1 -methylethyl)- 54868-48-3 Yes No - - ,(E)- 2,3’-dipyridyl 581-50-0 Yes No Yes No Butanal, 3-methyl- 590-86-3 Yes No Yes No 1 ,2-propanediol, 1-acetate 627-69-0 Yes No Yes No Tetradecane 629-59-4 Yes No Yes No Pentanal; Valeraldehyde 110-62-3 Yes No Yes No Cotinine; 2-Pyrrolidinone, 1- 486-56-6Yes Yes Yes Yes methyl-5-(3-pyridinyl)-, (S)- 1 ,6,10,14-hexadecatetraen- 1113-21-93-ol,3,7,11 ,15-tetramethyl- No Yes - - ,(E,E)- 3-Methyl-1 H-pyrazole-4- 112758-40- - - No Yescarbaldehyde 4Table 6: Concentration of Compounds in AerosolAve rag Ave rag e e ng / puff ng / puff Compound CAS No. (Aeroso (Aeroso I from I from Extract Extract 1) 2) Phenylacetaldehyde; Benzeneacetaldehyde 122-78-1 23 18Nonanal; Nonyl aldehyde; Aldehyde C-9; 124-19-6 311 4442,3-Pentanedione; Acetylpropionyl; 2,3-Pentadione 600-14-6 51 -Phenethyl alcohol; 2-Phenethyl alcohol; Benzyl carbinol 60-12-8 12 8Guaiacol; o-Methoxyphenol; o-Hydroxyanisole; Phenol, 2- 90-05-1 - 4 methoxy-Acetic acid; Ethanoic acid 64-19-7 739 -Ethanone, 1-(1 H-pyrrol-2-yl)- 1072-83-9 13 9Toluene 108-88-3 22 23Ethylbenzene 100-41-4 13 9Dodecane 112-40-3 1163 1020Cotinine; 2-Pyrrolidinone, 1 -methyl-5-(3-pyridinyl)-, (S)- 486-56-6 103 21Myosmine 532-12-7 92 672,3'-Dipyridyl 581-50-0 46 27Butanal, 3-methyl- 590-86-3 277 3461 ,2-Propanediol, 1-acetate 627-69-0 119 161Tetradecane 629-59-4 593 593Pentanal; Valeraldehyde 110-62-3 246 2543-Methyl-1H-pyrazole-4-carbaldehyde 1000484-37- - 1 31 ,6,10,14-hexadecatetraen-3-ol,3,7,11 ,15-tetramethyl-,(E,E)- 1113-21-9 71 -Example 3[000263] Further analysis was carried out to supplement the observations in the previous Examples. Four sample e-liquids were tested in non-combustible aerosol provision systems according to the present disclosure. The same device was used for all four samples. The objective of this Example was to determine whether any differences between the four sample e-liquids could be determined, with a focus on FMC-like tase and overall satisfaction score.[000264] The methodology of this test was sequential monadic testing (product placement with rotation). In this case, participants (n=355) were provided with the non-combustible aerosol provision systems containing the sample e-liquid and asked to use the products as they would normally as part of their daily routine for 2 days. Following placement, participants completed a sensorial evaluation by being asked a series of questions about the samples. The key drivers of an FMC-like taste that were evaluated included the tobacco taste likeability, aroma likeability, authenticity, smoothness of taste, aftertaste and sweetness. The key drivers of overall satisfaction that were evaluated include the drivers of the FMC-like taste, and additionally include physiological factors, such as the immediacy and sufficiency of the physiological response to the e-liquid, and sensorial factors, including irritation, chest sensation, smoothness of vapour and mouth drying, each of which contribute to the overall FMC experience and thus contribute to an overall satisfaction.[000265] Table 7 below details each sample tested.Table 7Sample No. E-Liquid Liquid Nicotine Benzoic AcidLevel (mg / mL) (Meq)1 Extract 1 10% 16 160 / 40 PG / VG2 Extract 1 10% 14 160 / 40 PG / VG3 Extract 2 10% 16 160 / 40 PG / VG4 Extract 28.5% 14 160 / 40 PG / VG[000266] Two comparative examples were also provided to participants and evaluated. This first comparative example is a commercially available tobacco-flavour e-liquid, which was chosen due to its popularity with smokers in the UK market. The commercially available tobaccoflavour e-liquid did not include limonene, 6-Ethyl-5,6-dihydro-2H-pyran-2-one, phenol, indole, alpha-linolenic acid, methoxyvinylphenol, guaiacol, acetic acid, 2-furanmethanol, 2-furancarboxyaldehyde,5-methyl, phenethylalcohol, 2(4H)-benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, or Octadecanoic acid.[000267] The second comparative example is a tobacco stick for use in a heated tobacco device, which was chosen due to its similarity with factory made cigarette, such as similarity in FMC-like taste and overall FMC-like experience.[000268] The results of the comparative analysis are provided in Table 8 below:Table 8Sample No. FMC-Like taste FMC-Like taste OSSvs Comparative vs Comparative vs Comparative Example 1 Example 2 Example 11 — —2 — — —3 + — —4 — —Key: “+” indicates improvement versus comparative example“ — ” indicates parity versus comparative example[000269] It can be seen that sample 3 has a superior FMC-like taste compared to comparative example 1 and has an equivalent scoring of the FMC-like taste when compared to comparative example 2, indicating that the presently disclosed extracts advantageously provide an FMC-like experience, such as FMC-like taste, to the consumer.[000270] The four samples were further tested as indicated above, however participants were divided between a full flavour (FF) solus and none-full flavour (NFF) solus. Full flavour cigarettes typically have a stronger, sometimes described as harsher or more intense, taste, whereas non-full flavour cigarettes are typically described as having a smoother taste[000271] Results of the comparative analysis are provided below in Table 9.Table 9Sample No. FMC-Like taste FMC-Like taste OSS (FF Solus)(FF Solus) (NFF Solus) vs Comparativevs Comparative vs Comparative Example 2Example 2 Example 21 —2 — — —3 — — —4 —Key: “+” indicates improvement versus comparative example“ — ” indicates parity versus comparative example[000272] It can be seen that samples 2 and 3 achieve an equivalent scoring of FMC-like taste in both the FF and NFF groups when compared to comparative example 2. Furthermore, the overall satisfaction score of samples 1-4 achieves an equivalent scoring to the FF group when compared to comparative example 2.[000273] Accordingly, it can be seen that a full flavour user has a similar overall satisfaction when using the disclosed samples 1-4 or when using the second comparative example. This advantageously demonstrates that, amongst a population full flavour users, the disclosed blends are able to provide just as effective experience as a commercially available product which more closely resembles an FMC.Example 4[000274] To further supplement the observations in the previous Examples, sample e-liquids were tested in a non-combustible aerosol provision system. The same device was used for all samples.[000275] The methodology of this test was sequential monadic product placement with block rotation. In this case, participants (n=300) were FMC users who were provided with a noncombustible aerosol provision system containing the sample e-liquid back-to-back and asked to use the products as they would normally as part of their daily routine for 2 days.[000276] A comparative example was also analysed - comparative example 2, as described above.[000277] Following placement, participants completed a sensorial evaluation and participants were scored on; Whether the e-liquid had an FMC-like taste and / or experience comparable with comparative example 2. Participants were asked a series of questions about the sample and the samples were assigned a mean score on a 7-point scale. The following drivers of FMC authentic taste were assessed: (1) Tobacco-taste likability; (2) aftertaste likeability; (3) aroma likeability; (4) taste intensity; (5) taste amount; and (6) taste consistency. (1)-(6) are listed in order of their importance for FMC authentic taste, with (1) being the most important and (6) being the least important.[000278] The samples being assessed are detailed in the table below.Table 10The samples being assessed were:Sample No. E-Liquid Liquid Nicotine Benzoic AcidLevel (mg / mL) and Lactic acid(Meq)5 Extract 1 10% 16 160 / 40 PG / VG6 Extract 1 10% 20 160 / 40 PG / VG[000279] The results of the sensorial evaluation are provided in the tables below.Table 11Sample TobaccoAftertaste Aroma Taste Taste Taste taste likability Likeability intensity amount consistency likabilityComparative 5.0 4.9 4.6 4.9 4.9 5.2 Example 2Sample 6 4.8 4.7 4.6 4.7 4.8 4.9Sample 5 4.9 4.8 4.8 4.6 4.8 4.8* * indicates significant difference at 95% confidence interval[000280] As can be seen, the top 5 drivers of FMC-like authenticity in both samples 5 and 6 are not significantly different from comparative example 2, indicating said samples provide an overall FMC-like experience.Example 5[000281] Further analysis was carried out to supplement the observations in the previous Examples. Four sample e-liquids were tested in non-combustible aerosol provision systems according to the present disclosure. The same device was used for all four samples.[000282] The methodology of this test was sequential monadic testing (product placement with rotation). In this case, participants (n=355) were provided with the non-combustible aerosol provision systems containing the sample e-liquid and asked to use the products as they would normally as part of their daily routine for 2 days.[000283] Following placement, participants completed a sensorial evaluation by being asked a series of questions about the samples. In particular, the sensorial factors evaluated which contribute to the overall FMC experience included irritation, chest sensation, smoothness of vapour and mouth drying. Participants assessed whether the factors were just right (“JR”), too much or not enough (e.g. too sweet, not sweet enough or just right).[000284] Table 12 below details each sample tested.Table 12Sample No. E-Liquid Liquid Nicotine Benzoic AcidLevel (mg / mL) (Meq)1 Extract 1 10% 16 160 / 40 PG / VG2 Extract 1 10% 14 160 / 40 PG / VG3 Extract 2 10% 16 160 / 40 PG / VG4 Extract 2 8.5% 14 160 / 40 PG / VG[000285] Two comparative examples were also analysed. These were the same as above. The first comparative example (“comparative example 1”) is a commercially available tobaccoflavour e-liquid, which was chosen due to its popularity with smokers in the UK market. The commercially available tobacco-flavour e-liquid did not include limonene, 6-Ethyl-5,6-dihydro-2H-pyran-2-one, phenol, indole, alpha-linolenic acid, methoxyvinylphenol, guaiacol, acetic acid, 2-furanmethanol, 2-furancarboxyaldehyde,5-methyl, phenethylalcohol, 2(4H)-benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, or Octadecanoic acid.[000286] The second comparative example (“comparative example 2”) is a tobacco stick for use in a heated tobacco device, which was chosen due to its similarity with factory made cigarette (FMC), such as similarity in FMC-like taste and overall FMC-like experience.[000287] The results of the comparative analysis are provided in Table 13 and 14 below.Table 13: Sensation analysis vs comparative example 1Sample No. Irritation (JR) Chest Sensation Smooth Vapour Mouth Drying (JR) vs Comparative (JR) (JR) vs Comparative Example 1 vs Comparative vs Comparative Example 1 Example 1 Example 11 — — —2 — — — —3 — — — —4 — — — —Table 14: Sensation analysis vs comparative example 2Sample No. Irritation (JR) Chest Sensation Smooth Vapour Mouth Drying (JR) vs Comparative (JR) (JR) vs Comparative Example 2 vs Comparative vs Comparative Example 2 Example 2 Example 21 —2 — — — —3 —4 — —Key: “+” indicates improvement versus comparative example (90% Confidence Interval) “ — ” indicates parity versus comparative example (90% Confidence Interval)[000288] All samples provide multiple FMC-like sensations, including irritation, smooth vapour and mouth drying that is at least equivalent to the FMC-like sensations provided by comparative example 1. Additionally, all samples advantageously provide a level of irritation that is at least equivalent to comparative example 2, thus providing an e-liquid which more closely provides an overall FMC-like experience.Example 6[000289] Four sample e-liquids were tested in a non-combustible aerosol provision system. The same device was used for each sample. The objective of this Example was to determine whether any differences between the four sample e-liquids could be determined, with a focus on irritation and overall FMC experience.[000290] The methodology of this test was sequential monadic testing in which the participants (n=12) evaluated multiple samples one at a time, completing the full sensory attributes for each sample before moving on to the next. A rating was given between 1 and 10, 1 being the lowest and 10 being the highest. The results are shown below; “NSD” means no significant difference versus the benchmark.[000291] A comparative example was also analysed (“comparative example 1”), which is a commercially available tobacco-flavour e-liquid, which was chosen due to its popularity withsmokers in the UK market. In this case, comparative example 1 contained 18.6 mg / ml nicotine. The commercially available tobacco-flavour e-liquid did not include limonene, 6-Ethyl-5,6-dihydro-2H-pyran-2-one, phenol, indole, alpha-linolenic acid, methoxyvinylphenol, guaiacol, acetic acid, 2-furanmethanol, 2-furancarboxyaldehyde,5-methyl, phenethylalcohol, 2(4H)-benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, or Octadecanoic acid.[000292] Table 15 below details each sample tested.Table 15Sample No. E-Liquid Tobacco liquid Nicotine Level Benzoic Acid extract (TLE) (mg / ml) (Meq) inclusion (%)1 Extract 1 8 18.6 1 60 / 40 PG / VG2 Extract 1 10 16.0 1 60 / 40 PG / VG3 Extract 1 10 14.0 1 60 / 40 PG / VG4 Extract 2 7 18.6 1 60 / 40 PG / VG5 Extract 2 10 16.0 1 60 / 40 PG / VG6 Extract 2 8.5 14.0 160 / 40 PG / VG[000293] Sample 1 of Table 16 was set as the benchmark against which irritation was evaluated amongst the samples containing extract 1. Sample 4 of Table 17 was set as the benchmark against which irritation was evaluated amongst the samples containing extract 2.[000294] The results of the comparative analysis are provided below in Tables 16 and 17.Table 16Sample No. Irritation Close to FMC Experience 1 3.6 5.3 2 NSD vs sample 1 NSD vs sample 13 NSD vs sample 1 NSD vs sample 1 Comparative example 1 (18.62.2 2.0mg nicotine)[000295] Comparative analysis reveals that sample 1 (Extract 1 with 18.6mg / ml nicotine and 8% TLE inclusion) has a statistically equivalent irritation and FMC experience in comparison to samples 2 and 3. However, comparative example 1 demonstrated decreased irritation and FMC experience versus the benchmark (sample 1). Accordingly, sample 1 delivers an improvedFMC-like experience, including in respect of irritation, versus a commercially available tobaccoflavour e-liquid.Table 17Sample No. Irritation Close to FMC Experience4 4.0 5.35 3.2 NSD vs sample 4 6 3.4 NSD vs sample 4 Comparative example 1 (18.6 2.2 2.0mg nicotine)[000296] Comparative analysis reveals that sample 4 (Extract 2 with 18.6 mg / ml of nicotine and 7% TLE inclusion) has improved irritation in comparison to samples 5 and 6, advantageously demonstrating that increased irritation can be effected by increasing nicotine and / or reducing TLE %. Furthermore, comparative example 1 demonstrated decreased irritation versus the benchmark (sample 4) and samples 5 and 6. Accordingly, sample 4-6 deliver an improved FMC-like experience in respect of irritation, versus a commercially available tobaccoflavour e-liquid. Sample 4 was also shown to deliver an overall closer FMC experience versus comparative example 1.[000297] Participants were further tasked with identifying the location of irritation according to a check-all-that-apply (“CATA”) approach. In particular, participants were asked to indicate whether irritation was detected in the mouth, nose, tongue, chest, throat and / or other for each of samples 1-6 and comparative example 1. The results are shown in Figures 1 & 2. It was found that for extract 1, as nicotine level was increased from 14.0 mg / ml to 18.6 mg / ml, directionally more irritation was perceived on the tongue. It was found that for extract 2, as nicotine level was increased from 14.0 mg / ml to 18.6 mg / ml, directionally more irritation was perceived on the mouth.Example 7[000298] To further supplement the observations in the previous Examples, sample e-liquids were tested in a non-combustible aerosol provision system as defined herein. The same device was used for all samples.[000299] The methodology of this test was sequential monadic product placement with block rotation. In this case, participants (n=300) were FMC users who were provided with aerosol provision systems containing the sample e-liquid back-back and asked to use the products as they would normally as part of their daily routine for 2 days.[000300] A comparative example was also analysed - comparative example 2, as described above.[000301] Following placement, participants completed a sensorial evaluation and participants were scored on; Whether the e-liquid had an FMC-like taste and / or experience comparable with comparative example 2. Participants were asked a series of questions about the sample. The following drivers of FMC authentic sensation were assessed: (1) smooth taste; (2) irritation; (3) mouth drying; (4) sweetness; (5) bitterness; and (6) warmth of vapour. Participants assigned driver (1) was assigned a mean score on a 7-point scale. Participants assessed whether drivers (2)-(6) were just right (“JR”), too much or not enough (e.g. too sweet, not sweet enough or just right) and the percentage of each calculated.[000302] The samples being assessed are detailed in the table below.Table 18Sample No. E-Liquid Liquid Nicotine Benzoic AcidLevel (mg / mL) and Lactic acid(Meq)5 Extract 1 10% 16 160 / 40 PG / VG6 Extract 1 10% 20 160 / 40 PG / VG[000303] The results of the sensorial evaluation are provided in the tables below.Table 19Sample Smooth Irritation Mouth Sweetness Bitterness Warmth of taste (7 pt (% JR) drying (% (% JR) (% JR) vapour (% scale) JR) JR) Comparative 4.2 67 65 69 71 82 Example 2Sample 6 4.3 63 74 67 67 80 Sample 5 4.4 68 70 64 77 78* indicates significant difference at 95% confid ence interval[000304] As can be seen, each of the drivers of FMC-like sensation authenticity in both samples 5 and 6 are not significantly different from comparative example 2, indicating said samples provide an overall FMC-like experience.Example 8Overview[000305] A non-targeted GCMS study was performed to analyse tobacco extracts 1 and 2 to identify the compounds present using chromatogram deconvolution and El library matching.A list of compounds of interest was searched for in the untargeted results and the concentration of said compounds was calculated over three replicates. The concentration of compounds of interest were calculated over a period of 12 months, with values generated at T = 0, 1, 3, 6, 9 and / or 12 months. Tobacco extract was stored at:• 25(±2)°C at 60(±5) % relative humidity (“Ambient” or “AMB”), or• 5(±3)°C (“Cold”).Materials and Methods[000306] 300 pL of a tobacco extract sample was weighed into a 50 mL centrifuge tube.10 mL of ethyl acetate was added to each sample which was then spiked with 100 pL of an internal standard (ISTD) solution. The ISTD was 1,4-dibromobenzene. Samples were shaken at 300 rpm for approximately 2 hours on a platform shaker. Aliquots of each sample were transferred into 2 mL GC autosampler vials for analysis. Samples were analyzed via GCMS operating in Scan mode using a Restek Rxi 5ms column (30m x 0.25mm x 0.25pm). Agilent Unknowns Analysis software was used to process all samples using chromatogram deconvolution to find compounds whose spectra were then compared against an in house PCDL and NIST 20 for identification. Semiquantitative concentration results were obtained from the relative response of I D / d compounds compared to the ISTD 1-4, dibromobenzene (approximate concentration of 500 ng / mL).Results[000307] Results are provided below in respect of extract 1 and extract 2 that were analysed as above.Stability of Flavour Compounds[000308] A number of flavour compounds was determined to be present in extract 2. These flavour compounds are indicated in the table below, and an exemplary concentration range for each flavour compound is indicated.Table 20Class Exemplary Extract 2 concentration range Flavour Compound (ug / g) (ug / g) 1 H-Pyrrole-2-carboxaldehyde,0.8 Smoke marker 0.1-201 -methyl- 2(4H)- Lactone 1-300 Benzofuranone, 5,6,7,7a- 3.0tetrahydro-4,4,7a-trimethyl-Ketone 0.1-8500.32-Furyl Methyl ketoneKetone 0.1-8501.3AcetoxyacetateAromatic Aldehyde 0.1-100.4BenzaldehydeAromatic Aldehyde 0.1-101.9BenzeneacetaldehydeSmoke marker 0.1-204.7Ethanone, 1-(1H-pyrrol-2-yl)- Smoke marker 0.1-202.8Ethanone, 1-(3-pyridinyl)- C5 to C24 fatty acid 1-5004.3Linolenic acidPalmitic acid (n-hexadecanoic C5 to C24 fatty acid 1-5007.3acid)Aldehyde 0.1-1002.7PentanalSubstituted Phenol 0.1-6002.3Phenol, 2-methoxy- Aromatic Alcohol 0.5-1004.4Phenylethyl AlcoholSmoke marker 0.1-200.5PyridineSmoke marker 0.1-300.4TolueneAromatic Aldehyde 0.1-100.1VanillinLactone 1-30011.2y-Butyrolactone[000309] GCMS Scan Flavour Analysis of the extract 2 was carried out over a period of 9 months with concentrations of each compound of interest calculated at T = 0, 1, 3, 6, 9 and / or 12 months under ambient or cold conditions. A concentration was also calculated after a 1 month accelerated period in which the extract was stored at 40(±2)°C at 75(±5) % relative humidity (“accel”). The concentration at T=0 is provided in the Table 21 below, wherein a V” indicates that the concentration remains within the exemplary range provided above.[000310] As indicated by Table 20 and 21, each of the flavour compounds shown maintain a concentration within the exemplary acceptable range over a period of at least T=3 months (e.g. acetoxyacetate), at least T=6 months (e.g. pentanal) and the majority for a period of T=9 months. Many flavour compounds are stable at T=12 months (e.g. linolenic and palmitic acid).[000311 ] A number of flavour compounds was determined to be present in extract 1. These flavour compounds are indicated in Table 22 below, and an exemplary concentration range for each flavour compound is indicated.Table 21Flavour Compound (ug / g) COLD AMB CO T=9 T=12 T= 1 H-Pyrrole-2-carboxaldehyde, 1-methyl- 2(4H)-Benzofuranone, 5,6,7,7a-tetrahydro- 4,4,7a-trimethyl- 2-Furyl Methyl ketone Acetoxyacetate Benzaldehyde Benzeneacetaldehyde Ethanone, 1 -(1 H-pyrrol-2-yl)- Ethanone, 1 -(3-py ridi ny I )- Linolenic acid Palmitic acid Pentanal Phenol, 2-methoxy- Phenylethyl Alcohol Pyridine Toluene Vanillin y-ButyrolactoneTable 23Flavour compound (ug / g) \ AMB ACCE AMB COLD \ AMB \ COLD AMB i COLD AMB ; COLD ; AMB \ COLD \ T=0 L T=1 T=1 T=1 \ T=3 \ T=3 : T=6 T=6 T=9 T=9 T=12 T=12 1H-Pyrrole-2-carboxaldehyde, 1- NA NA NA NA 2(4H)-Benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-1 2,3-pentanedione NA NA NA NA : NA NA NA \ NA 2-Furyl Methyl ketone NA NA NA NA NA NA NA Acetoxyacetate NA NA NA ; NA NA NA \ NA Benzeneacetaldehyde NA Ethanone, 1-(1H-pyrrol-2-yl)- Ethanone, 1 -(3-pyridinyl)- NA NA NA ; NA NA \ NA Furaneol NA NA NA \ NA Linolenic acid Myristic acid NA NA Palmitic acid Pentanal NA NA NA NA NA \ NA Phenol, 2-methoxy- NA Phenylethyl Alcohol Pyridine NA NA Toluene NA NAVanillin \ 4 4 4 J . NA NA NA 4 4 4 NA NA y-Butyrolactone \ 4 4 4 V \f \f 4 4 4 4Table 26Mouthful of Mouth Mouth Taste Tobacco Draw Compound Impact Irritation Bright-ness Dark-nesssmoke Drying Coating Intensity Aroma Resistance Isovaleric Acid Increase Increase Increase Increase Decrease Increase Increase Decrease Increase Increase 3-MethylpentanoicIncrease Increase Increase Increase Increase Increase Increase Decrease Increase Increase AcidPhenylacetic Acid Increase Increase Increase Increase Increase Increase Increase Decrease Increase Increase Valeric Acid Increase Increase Increase Increase Increase Increase Decrease Increase Decrease Increase Levulinic Acid Increase Decrease Increase Decrease Increase Decrease Decrease Increase Decrease Increase 2-Methylbutyric Acid Increase Increase Increase Increase Increase Increase Increase Decrease Increase Increase Isobutyric Acid Increase Increase Increase Increase Increase Increase Increase Increase Decrease Increase Acetic Acid Increase Increase Increase Increase Increase Increase Increase Decrease Increase Increase 2-methylvaleric acid No information available. Below the detection limit in FMC smoke.Benzoic acid Not an FMC-like markerHeptanoic acid Not an FMC-like markerButyric acid Not an FMC-like markerTable 22Class Exemplary Flavour compound Extract 1 concentration range (ug / g) (ug / g)1 H-Pyrrole-2- Smoke marker 0.1-20 carboxaldehyde, 1- 0.8methyl- 2(4H)- Lactone 1-300 Benzofuranone,3.45,6,7,7a-tetrahydro- 4,4,7a-trimethyl- Smoke marker 0.1-203.32,3-pentanedioneKetone 0.1-8500.52-Furyl Methyl ketoneKetone 0.1-8501.9AcetoxyacetateAromatic Aldehyde 0.1-101.5BenzeneacetaldehydeEthanone, Smoke marker 0.1-205.0pyrrol-2-yl)- Ethanone, 1-(3- Smoke marker 0.1-201.6pyridinyl)- Furan Derivative 0.1-500.9FuraneolC5 to C24 fatty acid 1-5007.9Linolenic acidC5 to C24 fatty acid 1-5001.0Myristic acidC5 to C24 fatty acid 1-50012.4Palmitic acidAldehyde 0.1-1002.8PentanalSubstituted Phenol 0.1-6001.8Phenol, 2-methoxy- Aromatic Alcohol 0.5-1004.6Phenylethyl AlcoholSmoke marker 0.1-200.7PyridineSmoke marker 0.1-200.4TolueneAromatic Aldehyde 0.1-100.2VanillinLactone 1-30012.0y-Butyrolactone[000312] GCMS Scan Flavour Analysis of extract 1 was carried out over a period of 12 months with concentrations of each compound of interest calculated at T = 0, 1, 3, 6, 9 and / or 12 months under ambient or cold conditions. A concentration was also calculated after a 1 month accelerated period in which the extract was stored at 40(±2)°C at 75(±5) % relative humidity (“accel”). The concentration at T=0 is provided in the Table 23 above, wherein a V” indicates that the concentration remains within the exemplary range provided above.[000313] As indicated by Table 22 and 23 above, each of the flavour compounds shown maintain a concentration within the exemplary acceptable range over a period of at least T=3 months (e.g. acetoxyacetate), at least T=6 months (e.g. pentanal) and the majority for a period of T=9 months. Many flavour compounds are stable at T=12 months (e.g. linolenic and palmitic acid).Example 9[000314] A difference between e-liquids obtained from tobacco liquid extracts compared to synthetic tobacco is the presence of naturally occurring acids in the tobacco extract. To understand the chemical and sensorial behaviour of such acids and identify alternatives to acids presently included in synthetic tobacco e-liquids (lactic acid and benzoic acid), a study was performed to determine the binding affinities of acids found naturally in tobacco to their cognate receptor, TRPV1. The reference compounds used in this study were benzoic acid and lactic acid. These molecules were selected as benchmarks to contextualize and compare the binding affinities obtained for the compounds of interest.[000315] The test compounds were: phenylacetic acid, heptanoic acid, 3-methylpentanoic acid, 2-methylvaleric acid, levulinic acid, 2-methylbutyric acid, isovaleric acid, valeric acid, isobutyric acid, butyric acid, and acetic acid.[000316] The affinity values considered throughout the analysis are the binding affinity scores (kcal / mol) obtained from compound-receptor interaction analyses derived from molecular docking simulations. These values represent the predicted strength of interaction between each ligand (test or reference compound) to the simulated molecular receptor.[000317] It will be appreciated by one skilled in the art that each of the compounds may be capable of binding to suitable receptors to act as the required agonist, antagonist or inhibitor. When a potential modulator interacts with a receptor then the interaction will have a given binding energy. The binding energy may be determined based on the follow equation:[000318] More specifically, the modulator and receptor involves several molecular interactions (e.g., van der Waals, electrostatic, hydrogen bonds, hydrophobic, and others) and physical-chemical complementarity among the receptor and the modulator. The protein structure file (receptor) may be retrieved from the Protein Data Bank and was described using electron microscopy model. The details are as follows: TRPV1: PDB: 7LR0, https: / / www.rcsb.org / structure / 7LRD, DOI: 10.2210 / pdb7lr0 / pdb. The receptors hydrogen atomsmay be added, according to appropriate hybridization geometry, to those atoms based on built-in modules to add partial charges, protonation states followed by bond orders assignment and set up rotatable bonds of the receptors.[000319] Active site pockets of a protein molecule are the sites where the potential modulators bind to a protein. To perform these experiments, one may use one simulation box that determinates the searching area for the modulators. This theoretical procedure may be performed using the TRPV1 grid-box size with dimensions of x=20 A, y= 20 A, z=20 A and a center coordinates of X=106.82 A, Y= 82.40 A, Z = 90.48 A.[000320] Gibbs free energy of binding (FEB in Kcal / mol) for complexes structures of a receptor - modulator may be calculated using a scoring function which approximates the chemical potentials (AGbind). The docking free energy of binding (FEBd0Ck) is defined by AGbindvalues for all docked poses of the formed complexes (protein- modulators) and include the internal steric energy of a given protein and modulators which can be expressed as the sum of individual molecular mechanics terms of standard-chemical potentials.[000321] A more negative value of FEB (kcal / mol) implies a higher affinity between thereceptor and the different types of modulator substrates. The docking simulation results may be categorized as energetically unfavorable when the Gibbs free energy of the formed complexes is AGbind> 0 kcal / mol, pointing either to extremely low or complete absence of binding affinity, otherwise they are categorized having medium to high docking affinity.[000322] The docking simulation results may be categorized as energetically unfavorable when the Gibbs free energy of the formed complexes is AGbind s 0 kcal / mol, pointing either to extremely low or complete absence of binding affinity.[000323] In summary, the FEB threshold is 0 kcal / mol. FEB values higher than 0 means an absence of affinity for the receptor. If FEB is lower than 0 kcal / mol, there was affinity for receptors. Lowest FEB values means a better affinity for receptor.[000324] The A affinity represents the difference in binding affinity between a test compound and a reference compound. This value is calculated relative to each reference compound (benzoic acid and lactic acid). For each receptor, the A affinity is computed as the absolute value of the difference between the docking affinity of a target compound and the docking affinity of the reference compound, according to the following expression:By way of example:• Butyric acid (test compound): affinity = -4.477 kcal / mol• Benzoic acid (reference): affinity = -6.169 kcal / mol8881 1 ( — -4.477) I®®[000325] This A affinity calculation was performed for both reference compounds, across all test compounds. The results of the affinity analysis are provided in Table 24 below. In Table 24, the affinity value of each acid for its receptor (kcal / mol) is described by whether it was more negative (i.e., a higher affinity) or less negative (i.e., a lower affinity) than the affinity value calculated for benzoic acid as a reference. In Table 24, the compounds have been ranked in orderof their A affinity, wherein 1 represents the smallest A affinity and 12 represents the largest A affinity, versus benzoic acid as a reference.Table 24Compound Affinity value A affinity(kcal / mol) compared rankingto referencePhenylacetic acid More negative 5Heptanoic acid More negative 13-Methylpentanoic acid Less negative 22-Methylvaleric acid Less negative 3Levulinic acid Less negative 42-Methylbutyric acid Less negative 6Isovaleric acid Less negative 7Valeric acid Less negative 8Isobutyric acid Less negative 9Lactic acid Less negative 10Butyric acid Less negative 11Acetic acid Less negative 12[000326] It can be seen how all acids tested were comparable in terms of A affinity to either benzoic acid or lactic acid.Example 10[000327] Following the results of the binding affinity study, the test acid compounds were analysed for their transfer efficiency from e-liquid to aerosol.[000328] Acids were measured in e-liquid and aerosol sample types using Gas Chromatography coupled with Mass Spectrometry (GC-MS) and were compared based on how much was proportionally detected in terms of w / w (mass balance). E-liquid measurements were a direct calculation. For aerosol measurements, using a smoking machine, the amount of e-liquid vaped was determined based on the mass of the remaining e-liquid. Accordingly, the acids were measured in the residual e-liquid, initial e-liquid and in the emission captured in a filter pad used in a smoking machine.[000329] To measure the acids in the e-liquid, 10 mg of e-liquid was weighed into a vialand 990 mL of isopropanol added. 10 pL of Naphthalene_d8 at 10000 ppm was then added and the solution vortexed for 15 seconds, checking for complete homogenisation. The solution was then injected into the GC-MS.[000330] To measure the acids in an aerosol sample, the e-liquid was vaped using a smoking machine (LM4) aligned with the angle to 15° and connect to an e-liquid device set to the holder, which contains a filter pad (e.g. a Cambridge filter (ml)). The smoking machine was programmed with the following specifications: 70 puffs, 3 seconds puff duration, 55 mL puff volume, 30 sec puff interval.[000331] The analyzed extract is generated from the smoking of 70 puffs and 15°. The smoking analysis is carried out in a linear smoking machine with one impinger containing 10 mL of extractive solution and 45 mm filter pad. Each sample was analyzed in at least 3 replicates. The filter pads used in the smoking process were conditioned for 48 hours at 25°C and a maximum relative humidity of 60%.[000332] After smoking using the smoking machine, the filter pad was transferred to a 125 mL Erlenmeyer flask and 10 mL of extractive solution added. The samples were shaken in an orbital shaker at 250rpm for 30 minute. The samples were filtered with an aliquot of each sample into a 2mL vial, which was then injected into the GC-MS.[000333] The concentration of each acid in the aerosol can thus be calculated as follows:Concentration (mg / mL)=((Aa / Ai-l)x C) / DAa = analyte area;Ai = Internal standard area;I = Standard curve intercept;C = Internal Standard concentrationD = Slope[000334] Accordingly, the transfer efficiency can be calculated based on how much was proportionally detected in terms of w / w in the e-liquid versus the aerosol.[000335] The results of this study are set out in Table 25 below.Table 25Compound Transfer efficiencyPhenylacetic acid 120%Heptanoic acid 93%Benzoic acid (reference) 100%3-Methylpentanoic acid 85%2-Methylvaleric acid 86%Levulinic acid 81%2-Methylbutyric acid 85%Isovaleric acid 93%Valeric acid 80%Isobutyric acid 81%Lactic acid 97%Butyric acid 83%Acetic acid 82%[000336] It can be seen how the transfer efficiency of each of the acids is close to 100%. Hence, a further study was performed to determine and compare the sensorial contributions of the acids in the FMC-like space.[000337] Sensory attribute models are obtained from data collected through structured sensory evaluations, in which a trained panel quantifies the intensity of specific attributes (such as mouthful of smoke, impact, irritation, mouth drying, mouth coating, taste intensity, tobacco aroma, brightness, darkness and draw resistance) using standardized scales.[000338] The trained panel refers to a sensory panel composed of assessors who are specifically selected and trained to evaluate products in a structured and consistent way. Theyare familiar with a defined sensory vocabulary and with assessing the intensity of specific attributes (such as aroma, taste, mouthfeel and related sensations) using standardized scales and reference standards.[000339] In parallel, while the sample is being assessed by the panel, it is also analyzed through a High-Throughput Screening (HTS) platform (or GC-MS Gas Chromatography-Mass Spectrometry), enabling the acquisition of its chemical fingerprint in an objective and reproducible manner. The chemical fingerprint is analyzed through machine learning models that can predict sensory aspects of FMC based on chemistry (as described in Soares et al.2020. Journal of Chemometrics).[000340] The integration of these sensory and chemical datasets allows the development of statistical or multivariate models that link perceptual attributes to specific chemical profiles.[000341] The correlation coefficient is a statistical metric that quantifies both the strength and the direction of the relationship between two variables, typically ranging from -1 to +1: positive values indicate that an increase in a given variable is associated with an increase in the sensory attribute (increase), whereas negative values indicate that an increase in the variable is associated with a decrease in the sensory attribute (decrease), enabling an objective interpretation of how chemical composition influences sensory perception.[000342] Table 26 above provides the direction for each tested compound in each attribute.[000343] As can be seen from the above data, whilst all acids had a comparable binding affinity and close to 100% transfer efficiency from the e-liquid to the aerosol, only isovaleric acid, 3-methylpentanoic acid, phenylacetic acid, valeric acid, levulinic acid, 2-methylbutyric acid, isobutyric acid and acetic acid were identified as markers of FMC-like sensorial attributes. Specifically, each of these acids were found to contribute to drivers of FMC-like sensation. For example, each acid demonstrates an increase in respect of irritation, indicating that the presence of each acid promotes irritation. Additional benefits of these acids are outlined below.[000344] Isovaleric acid, 3-methylpentanoic acid, phenylacetic acid, 2-methyl butyric acid, isobutyric acid and acetic acid each are capable of darkening the flavour profile. Valeric acid and levulinic acid each are capable of brightening the flavour profile.[000345] It may be desirable to ‘shift’ the profile of an aroma from a non-combustible substance delivery system to replicate and / or emphasise characteristics to mimic those of specific FMC products. For instance, as exhibited by certain tobacco varieties or blends thereof,such as Virginia, Burley, Oriental and the like. For example, Virginia may in some examples be characterised as brighter than other tobacco varieties, which may be associated with characteristics such as hay-like notes, lightness / mildness of flavour and or strength, and / or smoothness. Other varieties such as Oriental may be considered to have more complexity, depth and / or aromaticity. In some examples of FMC products, lighter and darker tobaccos may be combined in varying proportions to combine the foregoing characteristics to reflect consumer preference. By the terms “bright” and “dark”, is therefore meant modifying the aroma to “brighten” or “darken” towards that of a ‘bright’ tobacco and / or a ‘dark’ tobacco.[000346] The presence of the above-defined key irritation markers and key tobacco flavour markers in the aerosolised formulation, the formulation being obtained by aerosolising a composition in a non-combustible aerosol provision system, is advantageous for the reasons presented herein. In particular, these markers improve the ‘FMC-like’ experience delivered by the aerosol and thereby improve the sensorial experience of the consumer seeking to replicate smoking a tobacco product, such as a cigarette, with a non-combustible aerosol device such as a heated tobacco product or vaping system. The markers may include or be supplemented with one or more acids to “brighten” or “darken” the aroma. These advantages are coupled with those demonstrated for the composition from which the aerosolised formulation may be obtained.[000347] The various embodiments described herein are presented only to assist in understanding and teaching the claimed features. These embodiments are provided as a representative sample of embodiments only, and are not exhaustive and / or exclusive. It is to be understood that advantages, embodiments, examples, functions, features, structures, and / or other aspects described herein are not to be considered limitations on the scope of the invention as defined by the claims or limitations on equivalents to the claims, and that other embodiments may be utilised and modifications may be made without departing from the scope of the claimed invention. Various embodiments of the invention may suitably comprise, consist of, or consist essentially of, appropriate combinations of the disclosed elements, components, features, parts, steps, means, etc., other than those specifically described herein. In addition, this disclosure may include other inventions not presently claimed, but which may be claimed in future.

Claims

CLAIMS1. An aerosolised formulation obtained by aerosolising a composition in a noncombustible substance delivery system, the aerosolised formulation comprising at least one compound from group (a) and at least two compounds from group (b):a. 1,6,10,14-hexadecatetraene-3-ol,3,7,11,15-tetramethyl-, and 3-methyl-1H- pyrazole-4-carbaldehyde;b. Phenylacetaldehyde, Nonanal, Toluene, Ethylbenzene, Dodecane, 2,3’- dipyridyl, Butanal, 3-methyl-, 1,2-propanediol, 1 -acetate, Tetradecane, Pentanal, 2,3-pentanedione, 6,8-nonadiene-2-one, 8-methyl-5-(1 -methylethyl)-, and Guaiacol.

2. The aerosolised formulation according to claim 1, wherein the at least two compounds from group (b) include Butanal, 3-methyl-.

3. The aerosolised formulation according to claim 1 or claim 2, wherein the at least two compounds from group (b) are selected from: Phenylacetaldehyde, Nonanal, Toluene, Ethylbenzene, Dodecane, 2,3’-dipyridyl, 1,2-propanediol, 1-acetate, Tetradecane, Pentanal, 2,3-pentanedione, and 6,8-nonadiene-2-one, 8-methyl-5-(1-methylethyl)-.

4. The aerosolised formulation according to claim 3, wherein the formulation comprises at least three compounds from group (b).

5. The aerosolised formulation according to claim 3 or claim 4, wherein the at least one compound from group (a) is 1, 6, 10,14-hexadecatetraen-3-ol, 3, 7,11,15-tetramethyl-.

6. The aerosolised formulation according to claim 5, wherein 1,6,10,14-hexadecatetraen- 3-ol, 3, 7,11,15-tetramethyl- is present in an amount of at least about 60 ng / puff.

7. The aerosolised formulation according to claim 1 or claim 2, wherein the at least two compounds from group (b) are selected from: Phenylacetaldehyde, Nonanal, Toluene, Ethylbenzene, Dodecane, 2,3’-dipyridyl, 1,2-propanediol, 1-acetate, Tetradecane, Pentanal, and Guaiacol.

8. The aerosolised formulation according to claim 7, wherein the formulation comprises at least three compounds from group (b).

9. The aerosolised formulation according to claim 7 or claim 8, wherein the at least one compound from group (a) is 3-methyl-1H-pyrazole-4-carbaldehyde.

10. The aerosolised formulation according to claim 9, wherein 3-methyl-1H-pyrazole-4- carbaldehyde is present in an amount of at least about 0.1 ng / puff.

11. The aerosolised formulation according any preceding claim, wherein the concentration of the compounds from groups (a) and (b) in the formulation is at least about 500 ng / puff.

12. The aerosolised formulation according to claim 11, wherein the concentration of the compounds from groups (a) and (b) in the formulation is at least about 1000 ng / puff.

13. The aerosolised formulation according to any preceding claim, wherein the formulation further comprises phenethylalcohol, and ethanone, 1 -(1 H-pyrrol-2-yl)-, optionally in an amount of at least about 10 ng / puff.

14. The aerosolised formulation according to any preceding claim, wherein the formulation further comprises myosmine and cotinine, in an amount of at least about 75 ng / puff.

15. The aerosolised formulation according to any preceding claim, wherein the composition aerosolised in the non-combustible substance delivery system comprises at least one compound obtained by extraction from a tobacco material.

16. The aerosolised formulation according to any preceding claim, wherein the composition comprises at least one compound from group (a) and at least two compounds from group (b):a. 1,6,10,14-hexadecatetraene-3-ol,3,7,11,15-tetramethyl-, and 3-methyl-1H- pyrazole-4-carbaldehyde;b. Phenylacetaldehyde, Nonanal, Toluene, Ethylbenzene, Dodecane, 2,3’- dipyridyl, Butanal, 3-methyl-, 1,2-propanediol, 1 -acetate, Tetradecane, Pentanal, 2,3-pentanedione, 6,8-nonadiene-2-one, 8-methyl-5-(1 -methylethyl)-, and Guaiacol.

17. The aerosolised formulation according to claim 16, wherein the composition further comprises one or more compounds selected from: cotinine, myosmine, limonene, 3- methyl Pentanoic acid, phenol, 2-pyrrolidinone, 6-ethyl-5,6-dihydro-2H-pyran-2-one, nicotyrine, and 2,3-dihydro-benzofuran.

18. The aerosolised formulation according to claim 16 or claim 17, wherein the composition further comprises one or more compounds selected from: acetic acid, 2- furanmethanol, 2-Furancarboxaldehyde, 5-methyl-, Benzyl alcohol, Menthol, Indole, 2- Methoxy-4-vinylphenol, 6,8-Nonadien-2-one, 8-methyl-5-(1-methylethyl)-, Nicotyrine, 2(4H)-Benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, 2-Cyclohexen-1-one, 4-(3- hydroxybutyl)-3,5,5-trimethyl-, Cembrene, n-Hexadecanoic acid, Scopoletin, Octadecanoic acid, and 9,12,15-Octadecatrienoic acid.

19. The aerosolised formulation according to any of claims 16 to 18, wherein the composition further comprises cotinine, myosmine, limonene and nicotyrine, and optionally one or more compounds selected from 3-methyl Pentanoic acid, phenol, 2- pyrrolidinone, 6-ethyl-5,6-dihydro-2H-pyran-2-one, and 2,3-dihydro-benzofuran.

20. The aerosolised formulation according to any of claims 16 to 18, wherein the composition further comprises cotinine, myosmine, limonene, nicotyrine, acetic acid, 2- furanmethanol, 2-furancarboxaldehyde, 5-methyl-, menthol, 6,8-Nonadien-2-one, 8- methyl-5-(1 -methylethyl)-, 2-Cyclohexen-1-one, 4-(3-hydroxybutyl)-3,5,5-trimethyl-, Cembrene, n-Hexadecanoic acid, Octadecanoic acid, 9,12,15-Octadecatrienoic acid, and optionally one or more compounds selected from 3-methyl Pentanoic acid, phenol, 2-pyrrolidinone, 6-ethyl-5,6-dihydro-2H-pyran-2-one, 2,3-dihydro-benzofuran, Benzyl alcohol, Indole, 2-Methoxy-4-vinylphenol, Nicotyrine, 2(4H)-Benzofuranone, 5,6,7,7a- tetrahydro-4,4,7a-trimethyl-, and Scopoletin.

21. The aerosolised formulation according to any preceding claim, wherein the composition further comprises nicotine.

22. The aerosolised formulation according to any preceding claim, wherein the formulation comprises at least one organic acid selected from: isovaleric acid, 3-methylpentanoic acid, phenylacetic acid, valeric acid, levulinic acid, 2-methylvaleric acid, 2- methylbutyric acid, heptanoic acid, isobutyric acid, acetic acid, butryric acid, and combinations thereof.

23. The aerosolised formulation according to claim 22, wherein the at least one organic acid is selected from: phenylacetic acid, isovaleric acid, heptanoic acid, and combinations thereof.

24. The aerosolised formulation according to claim 22, wherein the at least one organic acid is selected from: isovaleric acid, 3-methylpentanoic acid, phenylacetic acid, valeric acid, levulinic acid, 2-methylbutyric acid, isobutyric acid, acetic acid, and combinations thereof.

25. The aerosolised formulation according to claim 24, wherein the at least one organic acid is selected from: isovaleric acid, 3-methylpentanoic acid, valeric acid, levulinic acid, 2-methylbutyric acid, isobutyric acid, acetic acid, and combinations thereof.